Dark | Light
# ![@dansfera Avatar](https://lunarcrush.com/gi/w:26/cr:youtube::UCvw9kVKHEyAlZPZ6ZuOd2VA.png) @dansfera Dan Sfera

Dan Sfera posts on YouTube about ai, future, fda, $aqst the most. They currently have [------] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.

### Engagements: [-----] [#](/creator/youtube::UCvw9kVKHEyAlZPZ6ZuOd2VA/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:youtube::UCvw9kVKHEyAlZPZ6ZuOd2VA/c:line/m:interactions.svg)

- [--] Week [------] +101%
- [--] Month [-------] +103%
- [--] Months [-------] +66%
- [--] Year [---------] +826%

### Mentions: [--] [#](/creator/youtube::UCvw9kVKHEyAlZPZ6ZuOd2VA/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:youtube::UCvw9kVKHEyAlZPZ6ZuOd2VA/c:line/m:posts_active.svg)

- [--] Week [--] -5%
- [--] Month [---] -41%
- [--] Months [-----] +113%
- [--] Year [-----] +837%

### Followers: [------] [#](/creator/youtube::UCvw9kVKHEyAlZPZ6ZuOd2VA/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:youtube::UCvw9kVKHEyAlZPZ6ZuOd2VA/c:line/m:followers.svg)

- [--] Week [------] +46%
- [--] Month [------] +103%
- [--] Months [------] +109%
- [--] Year [------] +119%

### CreatorRank: [-------] [#](/creator/youtube::UCvw9kVKHEyAlZPZ6ZuOd2VA/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:youtube::UCvw9kVKHEyAlZPZ6ZuOd2VA/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[finance](/list/finance)  28.78% [stocks](/list/stocks)  5.76% [countries](/list/countries)  2.16% [technology brands](/list/technology-brands)  0.72% [cryptocurrencies](/list/cryptocurrencies)  0.72%

**Social topic influence**
[ai](/topic/ai) 8.63%, [future](/topic/future) 7.19%, [fda](/topic/fda) 7.19%, [$aqst](/topic/$aqst) 6.47%, [investment](/topic/investment) 6.47%, [$iova](/topic/$iova) 5.76%, [market](/topic/market) 5.04%, [$6753t](/topic/$6753t) #1450, [food](/topic/food) 4.32%, [health](/topic/health) 4.32%

**Top accounts mentioned or mentioned by**
[@dansfera1r27gh4eutmmediumiosutmsourceprofile](/creator/undefined)

**Top assets mentioned**
[Iovance Biotherapeutics, Inc. Common Stock (IOVA)](/topic/$iova) [Atai Life Sciences B.V. (ATAI)](/topic/$atai) [ARS Pharmaceuticals, Inc. (SPRY)](/topic/$spry) [Intellia Therapeutics, Inc (NTLA)](/topic/$ntla) [Prime Medicine, Inc. (PRME)](/topic/$prme)
### Top Social Posts
Top posts by engagements in the last [--] hours

"FDA Says NO to Life-Saving Strip User Error This development surrounding Equestiv Therapeutics' innovative epinephrine film is a major eye-opener. Despite the drug's potential the FDA issued a Complete Response Letter reportedly due to critical patient non-compliance. It seems the issue wasn't the science behind the life-saving strip but how people were using itchewing spitting or placing it incorrectly on the tongue. A stark reminder that even the simplest delivery systems rely on perfect human execution. The implications for future rapid-response medical devices are significant."  
[YouTube Link](https://youtube.com/watch?v=6by9XKar068)  2026-02-12T20:11Z 85.9K followers, [--] engagements


"FDA Escalation: Case Lands at the DOJ When the head of the Food and Drug Administration actively directs a matter to the Department of Justice the implications are massive. This isn't a suggestion; it's a demand for investigation and action. Discover the real-world meaning behind this high-stakes referral and why observers are certain that significant developments are now inevitable. The outcome is the only question left unanswered. #FDA #DOJ #GovernmentAction #RegulatoryUpdate #LegalNews #Investigation DOJ FDA GovernmentAction Investigation LegalNews RegulatoryUpdate DOJ FDA GovernmentAction"  
[YouTube Link](https://youtube.com/watch?v=Iu1HdqxWq-s)  2026-02-14T22:11Z 86.2K followers, [--] engagements


"Aquestive Therapeutics $AQST Deep Dive With Biotech Scanner Biotech Scanner X: https://x.com/BIOTECHSCANNER CRIO: http://www.clinicalresearch.io Inato: https://go.inato.com/3VnSro6 Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 My podcast is Random Musings From The Clinical Trials Guru Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorr Text "guru" to 855-942-5288 to join VIP"  
[YouTube Link](https://youtube.com/watch?v=xWO8cmwaorE)  2024-07-24T17:52Z 85.9K followers, [---] engagements


"Oncology Clinical Trials Crash Course For Clinical Researchers and Biotech Investors Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorr Text "guru" to 855-942-5288 to join VIP list My blog:"  
[YouTube Link](https://youtube.com/watch?v=DGA1apsJ_Sg)  2025-11-18T12:00Z 86.2K followers, [----] engagements


"Unlocking the Future of Mental Health: DMT for Depression Explore the groundbreaking developments in mental health treatments as companies shift focus from traditional methods to more innovative solutions. The new intranasal DMT therapy is paving the way for effective options for treatment-resistant depression. With the recent release of promising phase 2B results the conversation around DMT as a potential game-changer in depression treatment continues to gain momentum. Insights from industry experts hint at a future where depression could be tackled in new ways never thought possible. Get"  
[YouTube Link](https://youtube.com/watch?v=DPiasOmIPFA)  2025-09-02T13:40Z 85.6K followers, [----] engagements


"This HIMS price is too high. Wait for the drop A frank look at the HIMS situation reveals a compelling argument for patience. The commentator suggests the current valuation is inflated and a further dip is likely before any real buying opportunity arises. Despite humorous disclaimers about their own investing success the underlying bearish sentiment is unmistakable. That quick bounce just might not be happening. #HIMSstock #StockMarket #Investing #Bearish #PricePrediction #MarketAnalysis Bearish HIMSstock Investing MarketAnalysis PricePrediction StockMarket Bearish HIMSstock Investing"  
[YouTube Link](https://youtube.com/watch?v=DmcC0gThi64)  2026-02-14T19:37Z 86.2K followers, [--] engagements


"Clinical Research Coordinator Interview Questions: How To Be Prepared LICR Link: https://www.linkedin.com/posts/latinos-in-clinical-research_latinosinclinicalresearch-diversityinclinicalresearch-activity-6960385322547343360-1lZiutm_source=linkedin_share&utm_medium=member_desktop_web The University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/ Text Me: (949) 415-6256 My podcast is Random Musings From The Clinical Trials Guru Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/dp/1090349521/. Text "guru" to"  
[YouTube Link](https://youtube.com/watch?v=H_x1XqLovTQ)  2022-08-08T19:51Z 82.7K followers, 47K engagements


"AI can't see this. Real human foresight in clinical trials Witness the critical skill separating seasoned clinical operations experts from nascent technology. A seasoned CRA's ability to intuitively pinpoint flaws in study designwhere patients or sites are most likely to stumblestems from deep multi-faceted fluency across the entire clinical landscape. That immediate pattern-recognition insight remains a uniquely human advantage over current artificial intelligence capabilities. #clinicalresearch #CRA #clinicaloperations #AIvsHuman #drugdevelopment #clinicaltrials #designintelligence"  
[YouTube Link](https://youtube.com/watch?v=ImsjG6g55PM)  2026-02-14T00:54Z 86.2K followers, [---] engagements


"CRO Trend Shocker: 5+ Years Experience is NOW a Liability The prevailing wisdom in clinical research monitoring just got a massive reality check. A surprising shift is hitting hiring practices where longevity in the fieldspecifically over five years of monitoring experienceis strangely becoming a drawback. Recruiters are reportedly seeking that "Goldilocks zone" of just two to three years on the resume. Discover the bizarre industry pivot that could redefine career paths for seasoned professionals. #CRO #ClinicalResearch #ClinicalTrials #Monitoring #CareerChange #JobMarket #CROJobs CRO"  
[YouTube Link](https://youtube.com/watch?v=Iz_44kxtUUc)  2026-02-08T21:36Z 85.9K followers, [--] engagements


"Stop Overthinking Your Trades Being Too Smart Can Cost You. A fascinating perspective on market timing suggests that deep expertise can actually sabotage potential profits. When one understands the nuances too well they might enter a position before mass adoption only to panic-sell during the slow initial phase. The paradox revealed here is that sometimes a lack of total knowledge allows an investor to hold on just long enough for the crowd to catch up leading to the real payday. A cautionary tale for the self-proclaimed experts. #investing #stockmarket #finance #mindset #tradingpsychology"  
[YouTube Link](https://youtube.com/watch?v=L0NGQSjTKcU)  2026-02-12T19:12Z 85.9K followers, [--] engagements


"Biotech Risks & Why This AI Mogul's Name Spooks Them. A deep dive into the shaky ground beneath certain biotech investments. Unpacking why relying on outsourced trials especially when certain high-profile figures are involved raises serious eyebrows for astute observers. An interesting perspective on where the real risks hide in the startup funding world. #BiotechInvesting #SamAltman #ChatGPT #CRO #StartupRisk #InvestmentAnalysis #TechSkeptic BiotechInvesting CRO ChatGPT InvestmentAnalysis SamAltman StartupRisk TechSkeptic BiotechInvesting CRO ChatGPT InvestmentAnalysis SamAltman StartupRisk"  
[YouTube Link](https://youtube.com/watch?v=OvyMNhzZZGU)  2026-02-13T00:03Z 86.2K followers, [---] engagements


"Site Networks: PE's 10X Return Dream or Imminent Pop The big question surrounding private equity's massive outlay for digital site networks revolves entirely around the exit. With demands for 7X or even 10X returns the entire model hinges on someone else eventually buying in at an even higher price. Analysts are watching closely to see if consolidators like the firms snapping up multi-million dollar portfolios represent the final stop for these assets. The sustainability of this high-stakes game is seriously being tested. #PrivateEquity #DigitalAssets #InvestmentBubble #WebsiteAcquisition"  
[YouTube Link](https://youtube.com/watch?v=c7Brw3bendc)  2026-02-14T21:16Z 86.2K followers, [--] engagements


"FDA Snag $100M Blunder Avoidable Witness the staggering fallout when site-level oversight fails. A single seemingly minor monitoring mistake has the power to derail a critical drug application translating directly into over one hundred million dollars in lost revenue and a year's delay for market access. The case of Equestiv Therapeutics and their innovative anaphylaxis treatment serves as a stark perhaps completely preventable warning to the entire pharmaceutical sector regarding regulatory adherence. #DrugApproval #FDA #Pharma #ClinicalTrials #SiteMonitoring #MedTech #Biotech"  
[YouTube Link](https://youtube.com/watch?v=f0Pw9OEi30Y)  2026-02-12T23:06Z 86.2K followers, [--] engagements


"CROs: Are they *really* saving you money The hidden profit trap revealed A fascinating look into the traditional Clinical Research Organization (CRO) model reveals a potential disconnect. One expert unpacks how those seemingly beneficial vendor relationships were often leveraged for the CRO's profit margin not the sponsor's bottom line. Discover the shift toward functional sourcing that's changing the game for trial budgets. #ClinicalTrials #CRO #HealthcareFinance #ClinicalResearch #Pharma CRO ClinicalResearch ClinicalTrials HealthcareFinance Pharma CRO ClinicalResearch ClinicalTrials"  
[YouTube Link](https://youtube.com/watch?v=j-l3ov56hgE)  2026-02-13T21:54Z 86.2K followers, [--] engagements


"Clinical Research Career Paths: PhDs and Assistants My substack FREE: https://substack.com/@dansfera1r=27gh4e&utm_medium=ios&utm_source=profile Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorr Text"  
[YouTube Link](https://youtube.com/watch?v=nxkqB1WcZEo)  2026-02-03T12:15Z 86.2K followers, 26.5K engagements


"David vs. Goliath in the legal world Can they catch up The conversation pivots to a fascinating showdown: a smaller legal entity facing off against a true industry behemoth King & Spalding reportedly pulling in billions annually. The sheer scale difference is staggering yet the ambition displayed is even bigger. Witness the sheer audacity of the challenger aiming to eclipse a $5 billion revenue giant in just a few more podcast appearances. A masterclass in competitive spirit. #lawfirm #legalbattle #davidvsgoliath #law #kingandspalding #smallbusiness #ambition ambition davidvsgoliath"  
[YouTube Link](https://youtube.com/watch?v=ssOS1q_5Qdo)  2026-02-12T19:58Z 86.2K followers, [--] engagements


"Miracle Cure Killed by Paperwork The $10M Tragedy. Witness the stunning corporate autopsy of a near-miracle pharmaceutical. Tens of millions poured into developing treatments that could change millions of livesonly for the entire venture to collapse. The reason A seemingly minor oversight in documenting patient feedback at scale. This story reveals a crucial often overlooked bottleneck in bringing truly life-altering therapies to the masses. It's a cautionary tale about how administrative details can eclipse scientific breakthrough. #DrugDevelopment #PharmaFailures #ClinicalTrials #Biotech"  
[YouTube Link](https://youtube.com/watch?v=xEYhduA4-ps)  2026-02-14T00:16Z 86.2K followers, [---] engagements


"GLP-1 Ad Wars: The Stock Market Showdown Revealed An interesting observation surfaces: the marketing focus isn't on a specific GLP-1 but on the *advertiser* itself seemingly drawing a sharp contrast with HIMS. Discover the subtle yet powerful shift in how pharmaceutical growth is being positioned and what this tactic might mean for the stock charts especially as one competitor seems to be taking a hit. A fascinating look at market positioning versus product promotion. #GLP1 #HIMS #PharmaMarket #StockAnalysis #HealthcareMarketing #InvestmentStrategy GLP1 HIMS HealthcareMarketing"  
[YouTube Link](https://youtube.com/watch?v=xRAVlzbyI80)  2026-02-15T00:28Z 86.2K followers, [---] engagements


"What Is A Clinical Research Coordinator and What Do They Do The University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/ Text Me: (949) 415-6256 My podcast is Random Musings From The Clinical Trials Guru Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/dp/1090349521/. Text "guru" to 855-942-5288 to join VIP list My blog: http://www.TheClinicalTrialsGuru.com My CRO and Site Network: http://www.DSCScro.com My CRA Academy: http://www.TheCRAacademy.com My CRC Academy: http://www.TheCRCacademy.com Latinos In"  
[YouTube Link](https://youtube.com/watch?v=yI-4_QuMysU)  2022-06-21T03:27Z 85.9K followers, 40.5K engagements


"The Only Crash Course To Clinical Research Youll Ever Need (full [--] hour OFFICIAL video) The Only Comprehensive Guide To Clinical Research Youll Ever Need (full [--] hour crash course) v.2019 (Make sure to watch in 1080p to avoid the lip sync lag) GET THE BOOK https://www.amazon.com/dp/1090349521/ref=mp_s_a_1_2crid=C7PR8LO0E2FC&keywords=the+comprehensive+guide+to+clinical+research&qid=1555945352&s=gateway&sprefix=the+comprehensive+guide+to+clinica&sr=8-2 Join this channel to get access to perks: https://www.youtube.com/channel/UCvw9kVKHEyAlZPZ6ZuOd2VA/join Text Me: (949) 415-6256 My podcast is"  
[YouTube Link](https://youtube.com/watch?v=yJNUq7bih8c)  2019-03-05T22:44Z 86.2K followers, 433.3K engagements


"The American Pharma Machine is about to get a serious turbocharge 🚀 A fascinating look into the strategic shift within US drug regulation. The pressure is mounting on the FDA to streamline the initial stages of drug developmentspecifically Phase [--] studies and IND approvalsas global competitors particularly China gain significant ground. What does this mean for research sites on the ground Experts suggest this move is designed to create an easier gateway for sponsors potentially leading to a significant uptick in clinical trial activity across the board. This is a major pivot in global"  
[YouTube Link](https://youtube.com/watch?v=-JVnuwGHFzs)  2026-02-08T16:39Z 71K followers, [---] engagements


"Some Biotech Stock Due Diligence - $AQST $IOVA With Biotechscanner and a bonus pick by me Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorr Text "guru" to 855-942-5288 to join VIP list My blog:"  
[YouTube Link](https://youtube.com/watch?v=-aj9TggmqZg)  2025-08-24T17:26Z 62.3K followers, [---] engagements


"Thermo Fisher Buys PPD: More Clinical Research Consolidation and Long Term Implications Thermo Fisher Buys PPD: More Clinical Research Consolidation and Long Term Implications"  
[YouTube Link](https://youtube.com/watch?v=-kAD_ETn3Qg)  2021-04-15T18:42Z 75K followers, [----] engagements


"Telehealth Giant's $4B Cap: Worth the Hype or DOJ Risk Observers are seriously questioning whether the leading telemedicine platform truly warrants its staggering $4 billion valuation. Is being the biggest enough to justify the price tag Experts suggest a market-cap comparison with rivals might be necessary to find an answer. Furthermore the shadow of the Department of Justice looms large prompting speculation that this industry behemoth might need to strategically conserve resources for upcoming challenges. A fascinating look at big tech's market reality. #Telemedicine #MarketCap #Valuation"  
[YouTube Link](https://youtube.com/watch?v=0qCGbwTn-uc)  2026-02-12T18:04Z 82.7K followers, [---] engagements


"7-Eleven vs. Your Doctor: The Placement Showdown Revealed. Corporations are reportedly pushing for studies that compare haphazard consumer placement of certain items against expert application. The ultimate goal appears to be clearing the path for widespread retail availability arguing that even if you grab it off the wrong shelf at a convenience store the outcome is essentially identical to advice given by a healthcare professional. That's a major shift in how self-care products might be sold. #OTC #retailstrategy #healthcare #consumerstudy #7eleven #pharmacy 7eleven OTC consumerstudy"  
[YouTube Link](https://youtube.com/watch?v=1PgZbfd7Y9o)  2026-02-07T21:51Z 75K followers, [---] engagements


"Biotech buyout rumors Wait for the dip not the hype. After years watching this biotech cycle an interesting pattern emerges around buyout speculation. The reality A "sell the news" event is highly probable meaning rushing in on buyout chatter could be a costly mistake. Observing this from the sidelines reveals a potential entry point after the initial euphoria fades not during. The long-term holder's perspective on when a true acquisition might actually become de-risked is surprisingly cautious. #Biotech #StockMarket #Investing #Buyout #StockStrategy #Trading Biotech Buyout Investing"  
[YouTube Link](https://youtube.com/watch?v=1R5cz0YwFtU)  2026-02-07T22:48Z 71K followers, [--] engagements


"Stop Dragging Your Feet Is Your Business Ready for the 'Instant' Economy The standard for operations has fundamentally shifted. What was acceptable in data processing just a few years agoa multi-day turnaroundis now an instant requirement from major players. This clip starkly illustrates the competitive pressure facing any network or business that refuses to embrace the latest technology setting the stage where yesterday's efficiency is today's disqualifier. It's a crucial peek into the new baseline for survival in a market that only rewards immediacy. #BusinessTrends #SpeedOfBusiness"  
[YouTube Link](https://youtube.com/watch?v=1d6XcHBygX8)  2026-02-09T17:57Z 75K followers, [---] engagements


"$NTLA $PRME & Beyond: Why These CRISPR Stocks Could Be HUGE Long-Term Investments Gene Investing With Anthony on X: https://x.com/GeneInvesting Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorr Text"  
[YouTube Link](https://youtube.com/watch?v=2Wv8wuHDvTI)  2025-05-27T22:56Z 75K followers, [---] engagements


"Six months to Q3 [----] NDA See the flaw. A crucial regulatory submission looms by Q3 [----] but the path there might be shorter than anticipated. Experts suggest studies can run concurrently drastically altering the six-to-nine month estimate. The surprising revelation Sophisticated financial minds seem to be overlooking this critical parallel processing possibility leaving a major timeline detail unaddressed. #NDAsubmission #BiotechTimeline #RegulatoryAffairs #FinancialAnalysis #PharmaNews BiotechTimeline FinancialAnalysis NDAsubmission PharmaNews RegulatoryAffairs BiotechTimeline"  
[YouTube Link](https://youtube.com/watch?v=3-FRR2f5CVQ)  2026-02-07T00:56Z 62.3K followers, [---] engagements


"Exit Strategy 2030: Are You Hitting The Target EBITDA 💰 See The Numbers That Matter A fascinating look into the financial benchmarks setting the stage for [----] business exits. The discussion reveals distinct EBITDA targets: a substantial $5 million valuation seems key for a full acquisition scenario. Alternatively for those seeking a Private Equity partnership focusing on scalability the entry point might sit closer to $1 million provided the growth trajectory is compelling. This perspective is crucial for founders currently in the thick of year four of their scaling journey. #BusinessExit"  
[YouTube Link](https://youtube.com/watch?v=30Ck9HQzw-4)  2026-02-07T19:30Z 62.3K followers, [---] engagements


"The ONE Small Form That Can Kill a Drug's FDA Approval. Experts reveal the shocking reality: administrative hiccups even a seemingly insignificant oversight like missing HIPAA consent documentation in mapping possess the power to derail an entire multi-million dollar drug approval process. Witness the intense scrutiny applied to study data via [---] observations and understand what critical procedural mistakes can jeopardize years of work and massive investments before the FDA. #drugapproval #clinicaltrials #FDA #compliance #HIPAA #medicalresearch #pharma FDA HIPAA clinicaltrials compliance"  
[YouTube Link](https://youtube.com/watch?v=3fccqLNZUjc)  2026-02-10T21:50Z 75K followers, [---] engagements


"$IOVA Stock: Next Big Biotech Win with [----] Catalysts Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorr Text "guru" to 855-942-5288 to join VIP list My blog: http://www.TheClinicalTrialsGuru.com My CRO"  
[YouTube Link](https://youtube.com/watch?v=3pKGwF3x_wk)  2025-09-29T18:14Z 75K followers, [---] engagements


"FDA Audits: It's Not Random Anymore Discover the surprising shift in the Food and Drug Administration's approach to site inspections. Learn how a deep dive into risk analysis dictates which clinical trial locations face scrutiny sometimes focusing on unexpected targets. Unpacking the crucial factors that flag a site for an official look like overwhelming patient enrollment numbers. This perspective changes everything about site compliance strategy. #FDA #ClinicalTrials #SiteAudits #RiskBasedAnalysis #RegulatoryCompliance #ClinicalResearch ClinicalResearch ClinicalTrials FDA"  
[YouTube Link](https://youtube.com/watch?v=3pjhXkbTLis)  2026-02-11T00:04Z 75K followers, [---] engagements


"Doctor vs. FDA: Who Decides Your Treatment A look at the surprising legal battle over ivermectin during the pandemic reveals a critical question: When regulatory bodies try to dictate a doctor's prescription where does patient choice end The courts once affirmed the doctor-patient relationship over FDA mandates but the landscape appears to be changing. This clip examines the fine line between medical guidance and governmental overreach in off-label drug use. #MedicalAutonomy #OffLabelUse #FDA #DrugRegulation #Ivermectin #HealthcareDebate #LegalBattle #PatientRights DrugRegulation FDA"  
[YouTube Link](https://youtube.com/watch?v=4aoKX17LsBQ)  2026-02-08T19:13Z 72.5K followers, [---] engagements


"Secret FDA loophole Drug approval *without* research Certain historical data carries surprising weight with regulators. An intriguing look at how a "paper NDA" can unlock drug approval pathways leveraging centuries-old usage data where traditional studies might fall short. For those tracking regulatory mechanics a peek into the FDA's own Manual of Administrative Procedures reveals operational insights that even keen observers might find illuminating regarding internal guidelines. #DrugApproval #FDA #Pharmaceuticals #MedicalNews #RegulatoryAffairs #HealthcareInnovation DrugApproval FDA"  
[YouTube Link](https://youtube.com/watch?v=4ymRMSisOeA)  2026-02-08T16:49Z 72.5K followers, [--] engagements


"The Million Dollar Gatekeeper: Is Your Business Ready for a PE Acquisition Unlocking the door to a lucrative private equity exit requires hitting a very specific financial benchmark. Observers note that interested PE firms are laser-focused on the trailing twelve months' performance. For a serious conversation to even begin the magic number they're looking for is a minimum of one million dollars in EBITDA from that recent yearly period. It's a non-negotiable starting point that separates the potential targets from the rest of the field. Understanding this TTM metric is crucial for anyone"  
[YouTube Link](https://youtube.com/watch?v=5AtHT_g0t3A)  2026-02-06T22:15Z 60.6K followers, [--] engagements


"OTC game-changer The path to front-of-store shelves revealed Experts weigh in on what it will take for this item to hit the over-the-counter market. Solid data and meticulous packaging are non-negotiable hurdles. A top executive noted the FDA's high bar for preventing medication errors even beyond just devices. What's the first domino that needs to fall for this accessibility shift #OTC #Pharmaceuticals #FDA #Approval #HealthInnovation #NextBigThing #DrugSafety Approval DrugSafety FDA HealthInnovation NextBigThing OTC Pharmaceuticals Approval DrugSafety FDA HealthInnovation NextBigThing OTC"  
[YouTube Link](https://youtube.com/watch?v=5N25O8hBfOU)  2026-02-04T01:15Z 82.7K followers, [---] engagements


"FDA CRL DROPS: Clarity or Confusion Ahead A close read of the recent FDA Complete Response Letter reveals surprising direction perhaps foreshadowing the agency's future OTC expanded access strategy. Analysts are zeroing in on the two swift easy-to-enroll studies mandated to address the feedback. This development offers fascinating insight into navigating unpredictable regulatory pathways. #FDA #Biotech #RegulatoryAffairs #ClinicalTrials #PharmaNews #CRL Biotech CRL ClinicalTrials FDA PharmaNews RegulatoryAffairs Biotech CRL ClinicalTrials FDA PharmaNews RegulatoryAffairs"  
[YouTube Link](https://youtube.com/watch?v=6Gy51SUhI6U)  2026-02-07T18:22Z 62.3K followers, [---] engagements


"Aquestive Therapeutics $AQST Is Bigger Opportunity Than We Even Thought Aquestive Therapeutics Is Bigger Opportunity Than We Even Thought"  
[YouTube Link](https://youtube.com/watch?v=6ke_6zXRI0Y)  2026-01-08T00:03Z 72.3K followers, [---] engagements


"PBMs are dying The future of medicine pricing revealed The traditional gatekeepers of prescription drug costs Pharmacy Benefit Managers might be facing obsolescence. Observers suggest a radical pivot toward a Direct-to-Consumer model is replacing how patients get their medicine. Hear the arguments for why the established system which dictates what big corporations' employees pay is finally crumbling. This discussion uncovers the emerging landscape of pharmaceutical access. #Pharmaceuticals #HealthcareReform #PBM #DirectToConsumer #DrugPricing #HealthTech #PharmacyBenefits DirectToConsumer"  
[YouTube Link](https://youtube.com/watch?v=7CjpU5LMmoM)  2026-02-13T16:36Z 86.2K followers, [---] engagements


"That iconic 'head in the sand' moment is happening right now in the tech world. Are you watching . The refusal to acknowledge massive shifts is more common than one might think. Network executives and even employees are reportedly choosing willful blindness imagining a reality where today's disruptive tools simply disappear. That approach is pure folly. Reality demands a clear-eyed look at what is unfolding and immediate adoption of the new landscape. The apprehension surrounding these changes is understandable but inaction is the far greater risk. It is time to look up and engage. #AI"  
[YouTube Link](https://youtube.com/watch?v=85qZxe5jwdg)  2026-02-08T00:49Z 75K followers, [---] engagements


"She Was Kicked Out of Zambia for Spying Now She Exposes Medical Fraud Edye Edens Edye's LinkedIn: https://www.linkedin.com/in/edyetedens/ My substack FREE: https://substack.com/@dansfera1r=27gh4e&utm_medium=ios&utm_source=profile Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK"  
[YouTube Link](https://youtube.com/watch?v=8ROy5pt2IXE)  2026-02-11T12:15Z 75K followers, [--] engagements


"What Is An IRT System In Clinical Research The University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/ Text Me: (949) 415-6256 My podcast is Random Musings From The Clinical Trials Guru Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/dp/1090349521/. Text "guru" to 855-942-5288 to join VIP list My blog: http://www.TheClinicalTrialsGuru.com My CRO and Site Network: http://www.DSCScro.com My CRA Academy: http://www.TheCRAacademy.com My CRC Academy: http://www.TheCRCacademy.com Latinos In Clinical Research:"  
[YouTube Link](https://youtube.com/watch?v=8t33h0wr54I)  2022-05-31T19:00Z 75K followers, [----] engagements


"Clinical Research Associate (CRA) Job Responsibilities CRIO: http://www.clinicalresearch.io Inato: https://go.inato.com/3VnSro6 Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 My podcast is Random Musings From The Clinical Trials Guru Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorr Text "guru" to 855-942-5288 to join VIP list My blog: http://www.TheClinicalTrialsGuru.com My"  
[YouTube Link](https://youtube.com/watch?v=9c5hGPwbWNw)  2024-05-09T12:15Z 75K followers, 12K engagements


"Forget the old way The FDA is tapping into predictive AI to radically change how drugs get appro. A fascinating look at the cutting edge of pharmaceutical regulation. The discussion reveals how the Food and Drug Administration is exploring a seismic shift in clinical trial architecture. Instead of rigid sequential stages advanced predictive analyticsspecifically Bayesian modelingare being examined to streamline the process. Imagine condensing phases one and two or two and three based on superior predictive pre-screening. This powerful statistical tool allows for a more predictive assessment"  
[YouTube Link](https://youtube.com/watch?v=ARDZt6ip_wI)  2026-02-10T01:46Z 75K followers, [---] engagements


"Forget $100 Million: This Risk Is Different. One analyst breaks down why this seemingly huge setback is financially a fraction of the expected disaster. The difference between a major write-off and a manageable contingency especially when contingent funding hangs in the balance changes the entire risk profile. A fascinating look at financial optics. #FinancialRisk #BusinessStrategy #Investment #Contingency #MarketAnalysis BusinessStrategy Contingency FinancialRisk Investment MarketAnalysis BusinessStrategy Contingency FinancialRisk Investment MarketAnalysis"  
[YouTube Link](https://youtube.com/watch?v=BJKUU1_2f_g)  2026-02-08T01:44Z 70.1K followers, [---] engagements


"The SCARY truth about letting algorithms run your life. Are you already obsolete A powerful perspective surfaces about the current push toward algorithmic dependency. Many people are unknowingly handing over their critical thinking which experts suggest could lead to being replaced by the very tools they rely on. One individual shares a defiant stance: rather than resisting the tools entirely the strategy becomes mastering the underlying principles to carve out a sustainable independent path even if it's not on the global stage. It's a sharp look at digital self-preservation and reclaiming"  
[YouTube Link](https://youtube.com/watch?v=ByqKUDa76Uw)  2026-02-09T16:09Z 75K followers, [---] engagements


"Bootlegging or Brilliant The HIMS Drug Debate The discussion dives deep into the questionable practices surrounding certain pharmaceutical marketing. What happens when a company markets a product variant without labeling it as such Hear the sharp exchange on whether this strategy crosses the line from clever formulation to outright imitation. Patients might be unaware of the subtle yet crucial differences in these treatments. A must-listen for anyone following the evolving landscape of accessible healthcare options. #HIMS #CompoundingPharmacy #DrugMarketing #HealthcareDebate #Pharmaceuticals"  
[YouTube Link](https://youtube.com/watch?v=CKvLVk9Ruw8)  2026-02-12T19:55Z 82.7K followers, [--] engagements


"Your Doctor Your Rx: Where Does the Line Get Drawn A fascinating exchange surfaces regarding medical autonomy. When a provider recommends a specific protocol involving new medications should the final approval rest solely between that expert and the individual receiving care The discussion takes a sharp turn when comparing this dynamic to restrictions placed on other specialized treatments. Explore the tension point where prescription power compounding pharmacy involvement and patient choice intersect. Its a critical look at who truly controls the path to wellness. #medical #autonomy #patient"  
[YouTube Link](https://youtube.com/watch?v=DvtYTac4064)  2026-02-12T01:03Z 82.7K followers, [---] engagements


"One bad site derails the whole drug trial Shocking truth The FDA's Form [---] looms large for research sites but sponsors might not fully grasp the immense risk. See how a seemingly small fraction of compromised data from just one underperforming site can seriously jeopardize an entire multi-million dollar clinical investigation. The ripple effect is far greater than most anticipate. #ClinicalTrials #DrugDevelopment #FDA483 #ResearchSite #PharmaRisk ClinicalTrials DrugDevelopment FDA483 PharmaRisk ResearchSite ClinicalTrials DrugDevelopment FDA483 PharmaRisk ResearchSite"  
[YouTube Link](https://youtube.com/watch?v=E2pXamrvT48)  2026-02-09T00:07Z 75K followers, [---] engagements


"Ditch the Corporate Ladder Why Smart Creators Are Choosing *Small* Over HUGE Networks 🤯 Perspective shift Many are finding that cultivating relationships within smaller site networks offers an unexpected sanctuary in today's digital landscape. While the trade-offs like potential financial instability or lack of traditional benefits are real considerations the gains in flexibility and genuine team collaboration paint a compelling picture. Workers finding themselves in these nimble environments are discovering a key advantage: instead of fearing replacement by automation they are being"  
[YouTube Link](https://youtube.com/watch?v=E7k5Lpn6_2A)  2026-02-09T00:12Z 71K followers, [---] engagements


"AI reveals hidden FDA red flags 🚩 Smart investors set up AI systems to instantly flag new FDA Warning Letters. Why this approach It provides a real-time pulse on regulatory scrutiny offering a crucial edge. For those holding stock sifting through these documents even with potential filler uncovers vital operational concerns missed by general market analysis. A sharp tactic for spotting lurking corporate vulnerabilities before they become headlines. #AI #StockMarket #FDA #InvestingTips #RiskManagement #TechAlerts AI FDA InvestingTips RiskManagement StockMarket TechAlerts AI FDA InvestingTips"  
[YouTube Link](https://youtube.com/watch?v=G95BLCdjatI)  2026-02-08T20:19Z 70.1K followers, [--] engagements


"$iova deep dive due diligence $iova deep dive due diligence"  
[YouTube Link](https://youtube.com/watch?v=Hz7SlMb18mQ)  2025-08-25T00:04Z 75K followers, [---] engagements


"StreamYard alternative DROPS the hammer 🤯 This deep dive exposes why creators are migrating from StreamYard to newer platforms boasting superior features like a handy countdown function. The core issue seems tied to its acquisition by Bending Spoons with many observers noting a sharp shift toward unwelcome business practices. It's the classic tale: a beloved tool receives massive investment leading users to feel progressively nickel-and-dimed. Discover the evidence suggesting the reign of the former streaming favorite might be coming to an end. #streaming #software #live #streaming"  
[YouTube Link](https://youtube.com/watch?v=IMd1SYzaGh0)  2026-02-10T18:18Z 75K followers, [---] engagements


"Career Pivots For Clinical Research Associates My substack FREE: https://substack.com/@dansfera1r=27gh4e&utm_medium=ios&utm_source=profile Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorr Text "guru""  
[YouTube Link](https://youtube.com/watch?v=Id4CbPQAuKo)  2026-02-10T16:51Z 75K followers, [---] engagements


"Gout Drug Approval: Centuries Too Late The pharmaceutical journey of colchicine offers a fascinating look at medical validation. Imagine proving what history already confirmed centuries ago This clip highlights a truly head-scratching moment in the quest for regulatory approval where a treatment historically associated with royalty and the rich finally gets its official modern stamp. A testament to process perhaps but certainly a prime example of the "No Shit Sherlock" phenomenon. #gout #colchicine #medicalhistory #fdaapproval #drugdiscovery #medicalfacts #historyofmedicine colchicine"  
[YouTube Link](https://youtube.com/watch?v=J5hVoZYDXyA)  2026-02-09T23:14Z 75K followers, [---] engagements


"HIMS: Buy the Dip or DOJ Danger Zone The fate of HIMS hangs in the balance. Observers are seriously debating whether the recent stock slump presents a compelling entry point or if lingering regulatory shadows make it too risky. Analysts dissect the current billion-dollar market cap and ponder what the next chapter for this health platform truly holds. The conviction level remains mixed making this a critical moment for potential investors to watch. #HIMS #StockMarket #Investing #HealthTech #StockAnalysis #DOJ DOJ HIMS HealthTech Investing StockAnalysis StockMarket DOJ HIMS HealthTech"  
[YouTube Link](https://youtube.com/watch?v=J8Jm2XWenp8)  2026-02-11T19:25Z 75K followers, [----] engagements


"SCENARIO SHIFT: The FDA boogeyman is gone. What does this mean for the future of innovation and i. A major shift is underway concerning federal oversight. Observers note that the period of paralyzing regulatory doubt has concluded. Far from stifling progress the current climate appears aligned with accelerating scientific exploration though the pathway itself is being re-engineered. Forget the old mandates; the established multi-phase testing structure is facing serious scrutiny perhaps streamlining processes akin to those used for expedited pathways. The underlying drive appears to be"  
[YouTube Link](https://youtube.com/watch?v=Mc6ZawsaYTs)  2026-02-08T19:57Z 75K followers, [---] engagements


"Is IOVA the next big thing Find out why this investor couldn't resist adding more shares The latest developments surrounding IOVA are creating quite a buzz in the investment community. With its promising trial results the outlook for laphylocel and non-small cell lung cancer has never looked brighter. An enthusiastic investor shares their perspective on this stock explaining the rationale behind their recent purchase and how everything points toward a strong future for the company. Could this be the opportunity you've been waiting for Discover the insights behind the hype and why this is a"  
[YouTube Link](https://youtube.com/watch?v=NoYb3fYjvmo)  2025-11-11T01:22Z 62.3K followers, [---] engagements


"$ATAI Stock: AtaiBeckley FDA Breakthrough Status & The $12 Target: BPL 003's [--] Hour Game Changer Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorr Text "guru" to 855-942-5288 to join VIP list My blog:"  
[YouTube Link](https://youtube.com/watch?v=OeBFvuRb4LA)  2025-11-13T02:31Z 75K followers, [---] engagements


"AI is lying to you. See why Serious decisions require more than a string of AI answers. A startling realization emerges: relying on multiple AI models is just having one algorithm second-guess another. Discover the critical flaw in current large language model output that mandates human oversight for any sensitive information. The data simply isn't there yet for blind faith. #AI #ArtificialIntelligence #DataTrust #LLM #TechWarning #FutureofWork AI ArtificialIntelligence DataTrust FutureofWork LLM TechWarning AI ArtificialIntelligence DataTrust FutureofWork LLM TechWarning"  
[YouTube Link](https://youtube.com/watch?v=PN3qcf7fXPs)  2026-02-11T01:37Z 75K followers, [---] engagements


"Are YOU asking the RIGHT questions 🤯 This simple approach uncovers HUGE blind spots A fascinating look at the relentless pursuit of improvement One individual discovers that their intense curiosity and barrage of clinical questions aimed at ironing out inefficiencies and identifying gaps places them high on the internal poll of most inquisitive team members. The real takeaway Even someone who thinks they ask *all* the questions isn't actually number one Discover the mindset that drives constant evolution and why relentless inquiry is a sign of genuine engagement not annoyance. A must-watch"  
[YouTube Link](https://youtube.com/watch?v=Pm4ClrG8Dgo)  2026-02-09T18:48Z 75K followers, [---] engagements


"That infamous [---] audit screenshot Total noise See the real story. The story circulating about the January [----] manufacturing audit findings gets a complete reversal here. What was presented as a major red flagthat dreaded Form [---] screenshotturns out to be pure noise based on incomplete data. Reviewing the supposed evidence even under worst-case assumptions demonstrates why this particular piece of information should be ignored. A fascinating look at how easily miscontextualized data can cause industry panic. #FDAAudit #ManufacturingCompliance #Form483 #AuditDebunked #IndustryAnalysis"  
[YouTube Link](https://youtube.com/watch?v=Puw5bjQzCIk)  2026-02-07T19:56Z 62.3K followers, [---] engagements


"$SPRY Neffy Citizens Petition To FDA To Block $AQST Anaphylm Analysis Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorr Text "guru" to 855-942-5288 to join VIP list My blog:"  
[YouTube Link](https://youtube.com/watch?v=QXRQG1mb5YU)  2025-10-29T00:30Z 75K followers, [---] engagements


"Congress writes laws. The FDA decides life or death. The scope of Congressional law like the Food Drugs and Cosmetics Act often leaves critical details vague. Observe how the Executive Branch agencies such as the FDA must translate sweeping mandates like "no adulteration" into highly specific nuanced rules for cutting-edge fields like gene therapya translation with potentially life-or-death consequences. It's fascinating to see the gap between initial lawmaking and its complex real-world enforcement. #FDA #Regulation #GeneTherapy #LawInterpretation #FDCA #ExecutiveBranch ExecutiveBranch FDA"  
[YouTube Link](https://youtube.com/watch?v=QaDR6cNDD6I)  2026-02-09T01:32Z 72.5K followers, [---] engagements


"The Miami Meltdown With Edye Edens: Could This Scandal Change the CRO/Sponsor Relationship Forever Edye's LinkedIn: https://www.linkedin.com/in/edyetedens/ My substack FREE: https://substack.com/@dansfera1r=27gh4e&utm_medium=ios&utm_source=profile Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK"  
[YouTube Link](https://youtube.com/watch?v=Qi-PFvJLmUk)  2026-01-22T12:15Z 62.3K followers, 13.2K engagements


"The SECRET behind free EMR tools Hint: It's not kindness. 🤯 This segment exposes the surprising calculus behind seemingly generous health system practices. Offering Electronic Medical Records (EMRs) and essential tools for free isn't about pure charity; it's a strategic play for the ultimate commodity. As AI dominates the scarcity shifts entirely to high-quality real-world data. The old adage "Garbage in garbage out" underscores why access to genuine patient information has become the new gold standard making it the real price of admission for any advanced toolset. #DataIsTheNewGold"  
[YouTube Link](https://youtube.com/watch?v=QwBV0iQTxH0)  2026-02-05T21:01Z 62.3K followers, [---] engagements


"Clinical Trials: The Real Price Tag & Investor Payday. Someone deeply embedded in research site operations reveals the staggering financial reality behind getting crucial clinical study data. Discover the typical budget ranging from $750000 to $1.5 million and the tight four-to-six-month window from first to last patient. The real kicker The market's predictable reaction once those numbers are finalizedoften resulting in a rapid 15% to 20% boost for the associated stock. An insider look at how science meets the market. #ClinicalTrials #BiotechInvesting #PharmaFinance #StockMarketInsights"  
[YouTube Link](https://youtube.com/watch?v=RM1MUpoBW0s)  2026-02-07T23:56Z 75K followers, [---] engagements


"Bought the 40% surge top High conviction play or instant regret A classic market moment captured: one investor fueled by positive news and excitement dives back in right as a stock rockets up 40%. The purchase was made near the peak doubling down after a previous strategic move to reduce risk in the last cycle. A fascinating look at the psychology of chasing a massive gainwas this bravery or folly The conviction remains even after buying at the high. #stockmarket #investing #trading #FOMO #stockanalysis #momentumtrading FOMO investing momentumtrading stockanalysis stockmarket trading FOMO"  
[YouTube Link](https://youtube.com/watch?v=RMKejHimqu8)  2026-02-05T23:42Z 56.5K followers, [---] engagements


"Mastering the Chaos of Clinical Trials Navigating the world of clinical trials isn't for the faint of heart. Balancing responsibilities across [--] to [--] studies while collaborating with multiple Clinical Trial Managers (CTMs) and Clinical Research Associates (CRAs) requires not only skill but also finesse. Discover the intricacies of project management in clinical research where efficient resource allocation and team coordination are paramount. Gain insights into the challenges faced by project managers and learn how they ensure success across diverse studies from site management to team"  
[YouTube Link](https://youtube.com/watch?v=RVwdYrfRvG0)  2025-01-23T06:57Z 82.7K followers, [----] engagements


"Oversight Gone The Miami Sponsor Nightmare. When an organization completely delegates oversight disaster often follows. The recent Miami sponsor situation serves as a stark warning: relying solely on an external expert like a CRO to manage everything leaves a massive liability gap if they stumble. True control can never be fully offloadedthe consequences of that lapse are severe. This segment dissects where the line between hiring help and losing the reins gets dangerously blurred. #BusinessRisk #Outsourcing #CRO #RiskManagement #BrandSafety #CorporateGovernance BrandSafety BusinessRisk CRO"  
[YouTube Link](https://youtube.com/watch?v=S1-N02I3WUY)  2026-02-12T18:19Z 82.7K followers, [---] engagements


"Clinical Research Study Start Up Regulatory Documents Explained Quickly The University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/ Text Me: (949) 415-6256 My podcast is Random Musings From The Clinical Trials Guru Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/dp/1090349521/. Text "guru" to 855-942-5288 to join VIP list My blog: http://www.TheClinicalTrialsGuru.com My CRO and Site Network: http://www.DSCScro.com My CRA Academy: http://www.TheCRAacademy.com My CRC Academy: http://www.TheCRCacademy.com"  
[YouTube Link](https://youtube.com/watch?v=SAdHZYYSzJ4)  2022-03-26T00:24Z 70.8K followers, 18.9K engagements


"FDA Rejection The Details Might Surprise You. The market's reaction might be overblown. This analysis reveals why the recent Complete Response Letter is characterized as 'clean'restricted only to mechanical hurdles with management explicitly stating the FDA raised zero red flags regarding critical clinical endpoints like blood pressure or variability. Wait for the official release to confirm the full story behind this hurdle. #FDA #CRL #BiotechNews #DrugApproval #InvestmentInsights #PharmaUpdate BiotechNews CRL DrugApproval FDA InvestmentInsights PharmaUpdate BiotechNews CRL DrugApproval FDA"  
[YouTube Link](https://youtube.com/watch?v=SDtOqygdXSM)  2026-02-06T01:59Z 56.5K followers, [---] engagements


"Speed vs. Safety: How Fast Should Cures Arrive 🤯 The burning question surfaces: Should clinical trial timelines be drastically cut While safety remains paramount a powerful argument emerges for accelerating innovation. Discover the tension between a patient's desire for quicker access to potential breakthroughs and the rigorous standards protecting public health. Where does the line truly get drawn for established safety benchmarks versus rapid efficacy testing A fascinating look at the core dilemma facing modern medicine. #FDA #ClinicalTrials #PatientSafety #DrugApproval #MedicalEthics"  
[YouTube Link](https://youtube.com/watch?v=T65gRsQ176Q)  2026-02-08T17:26Z 75K followers, [---] engagements


"CROs: Record Profits or Race to the Bottom The pursuit of bottom-line growth by publicly traded CROs hints at a worrying downward spiral for clinical research standards. While some industry analysts report record profits regulatory red flags including spikes in inadequate monitoring detailed in FDA reports suggest sponsors may soon tire of the current cost-cutting environment. Observers suggest the writing is on the wall for CRO market share against more agile site networks. A fascinating look at where the industry's financial incentives are currently leading. #ClinicalResearch #CROs"  
[YouTube Link](https://youtube.com/watch?v=TJm-zN9KwzE)  2026-01-31T01:12Z 71K followers, [---] engagements


"They Bought 5k Shares Will This Stock Reach $7 The $7 upside for this particular stock seems plausible based on the anticipated trial results. An investor just added [----] shares to their position viewing anything under $5 as an excellent entry point. Important milestones ahead include a Type A meeting and the launch of key studies culminating in an NDA submission in the third quarter. The countdown to major catalysts is officially on #StockMarket #PricePrediction #InvestmentStrategy #MarketCatalyst #FinancialNews FinancialNews InvestmentStrategy MarketCatalyst PricePrediction StockMarket"  
[YouTube Link](https://youtube.com/watch?v=TZV8a8FjRqY)  2026-02-06T23:47Z 71K followers, [---] engagements


"AI is coming for the budget: Prepare for the squeeze 📉 A stark look at the near future where the integration of artificial intelligence and aggressively streamlined processes become the new standard. The consensus points toward a 'take it or leave it' approach to corporate budgeting inevitably tightening financial margins across the board for the coming ten years. Essential viewing for anyone planning their strategy for the next decade. #AI #BusinessStrategy #FutureOfWork #Finance #Automation #TechTrends #Economy #MarginSqueeze #YouTubeShorts AI Automation BusinessStrategy Economy Finance"  
[YouTube Link](https://youtube.com/watch?v=U4hNxRzr5ls)  2026-02-09T20:41Z 75K followers, [--] engagements


"Epinephrine Film: PDUFA Battle Why ARS Pharma $spry is Trying to Delay Anaphylm Approval $AQST OASIS study presentation: https://investors.aquestive.com/static-files/46303091-5060-4893-bb80-7be00a833927 Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK"  
[YouTube Link](https://youtube.com/watch?v=UMHqq-cMdH8)  2025-11-12T00:17Z 75K followers, [---] engagements


"The SECRET to multi-location business growth It's all about the tech you standardize 🚀 Achieving true platform status demands more than just local success; it requires proving the ability to scale geographically with absolute consistency. This piece explores the crucial strategy: codifying the entire technology ecosystemfrom patient management systems like Creo and Patient Ace to workflow tools like Monday and Gleaminto a single replicable blueprint. The logic is simple: any future partner or new site inherits a fully operational proven framework making rapid repeatable expansion the only"  
[YouTube Link](https://youtube.com/watch?v=UYf577DlKN0)  2026-02-08T21:23Z 75K followers, [--] engagements


"What Makes Oncology Clinical Trials Unique From Others - A Clinical Research Site Perspective Join this channel to get access to perks: https://www.youtube.com/channel/UCvw9kVKHEyAlZPZ6ZuOd2VA/join Text Me: (949) 415-6256 My podcast is Random Musings From The Clinical Trials Guru Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/dp/1090349521/. Text "guru" to 855-942-5288 to join VIP list My blog: http://www.TheClinicalTrialsGuru.com My CRO and Site Network: http://www.DSCScro.com My CRA Academy: http://www.TheCRAacademy.com My CRC"  
[YouTube Link](https://youtube.com/watch?v=UZS3j8pOsLE)  2021-11-30T19:52Z 82.7K followers, [----] engagements


"CRA Followed & Threatened in Miami The Wildest Clinical Research Fraud Allegations Exposed Carla's LinkedIn: https://www.linkedin.com/in/carla-vera-navas-9b5a2439/ My substack FREE: https://substack.com/@dansfera1r=27gh4e&utm_medium=ios&utm_source=profile Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK"  
[YouTube Link](https://youtube.com/watch?v=UqG6cCbvmTU)  2026-01-15T23:32Z 75K followers, 27.2K engagements


"What Are My Thoughts On Masters In Clinical Research Degrees What Are My Thoughts On Masters In Clinical Research Degrees Text Me: (949) 415-6256 My podcast is Random Musings From The Clinical Trials Guru Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/dp/1090349521/. Text "guru" to 855-942-5288 to join VIP list My blog: http://www.TheClinicalTrialsGuru.com My Private Member Patreon Page: http://www.patreon.com/dansfera My CRO and Site Network: http://www.DSCScro.com My CRA Academy: http://www.TheCRAacademy.com My CRC Academy:"  
[YouTube Link](https://youtube.com/watch?v=VkVnSxSMEsQ)  2021-06-01T15:03Z 75K followers, [----] engagements


"HIMS at $17: Rocket to $8 or massive crash The DOJ is watching A sharp look at HIMS as it trades near seventeen. Analysts are openly debating whether this stock is primed for an explosive move to eight dollars or beyond. The underlying sentiment suggests fear is at an all-time high fueled by the serious implications of the FDA escalating matters to the Department of Justice. This development signals a long road ahead contrasting sharply with recollections of buying at the previous six-figure peak valuation. The charts tell a compelling albeit nervous story. #HIMS #StockMarket #FDA #DOJ"  
[YouTube Link](https://youtube.com/watch?v=WZQno7rKhDM)  2026-02-11T16:36Z 75K followers, [---] engagements


"$Iova with the earnings turnaround Stock pumps $Iova with the earnings turnaround Stock pumps"  
[YouTube Link](https://youtube.com/watch?v=Xs2XyRp0obs)  2025-11-06T23:12Z 75K followers, [---] engagements


"FDA Cracks Down On $HIMS and Others FDA Cracks Down On $HIMS and Others"  
[YouTube Link](https://youtube.com/watch?v=XytGxvIg6pc)  2026-02-10T20:20Z 75K followers, [---] engagements


"FDA's bizarre guidance move explained A fascinating procedural anomaly has surfaced: The Food and Drug Administration issued crucial labeling instructions within the Complete Response Letter itself a step usually reserved for the earlier review phase. Observers noted this break from convention during the call. Could this highly unusual action signal that regulators are meticulously setting the stagegathering necessary data and precedentfor a future over-the-counter pilot product launch An interesting perspective on agency strategy. #FDA #RegulatoryAffairs #DrugApproval #LabelingGuidance #OTC"  
[YouTube Link](https://youtube.com/watch?v=Y1klOpoTdX4)  2026-02-04T23:51Z 75K followers, [---] engagements


"De-risked and Boring $AQST and Excitement Filled $IOVA - Biotech Stock Talk AQST and IOVA Biotech Stock Talk"  
[YouTube Link](https://youtube.com/watch?v=YCTzxX1-Je4)  2026-02-03T23:01Z 75K followers, [---] engagements


"The shocking reason hospitals are running out of essential meds. The economics of pharmaceuticals reveal a startling vulnerability in healthcare. When generic drug margins shrink to 'paper thin' manufacturers simply walk away causing a cascade effect. Imagine a hospital facing empty shelves where life-saving chemotherapy should be. The reality involves technicians frantically compounding essential medications just to keep patients alive. Discover the systemic failure behind the alarming rise in critical drug shortages. #drugshortages #pharmaceuticals #healthcarecrisis #genericdrugs"  
[YouTube Link](https://youtube.com/watch?v=YWkHbHyUsd4)  2026-02-13T01:44Z 86.2K followers, [----] engagements


"$AQST Aquestive Therapeutics' Clean CRL - You Have [--] Months To Load Up My substack FREE: https://substack.com/@dansfera1r=27gh4e&utm_medium=ios&utm_source=profile Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK"  
[YouTube Link](https://youtube.com/watch?v=YwhhSFXUA6w)  2026-02-02T23:28Z 75K followers, [---] engagements


"FDA Inspectors: Who's really at fault Site vs. Protocol breakdown Unpacking the tough reality behind failed FDA site inspections. When two sites stumble on the same process is the issue the people or is the foundational study guide itself flawed Discover the critical shift in perspective when determining accountability for reporting failures. This analysis separates the site's execution from the protocol's design. #FDAReview #ClinicalTrials #SiteAudit #ProtocolDesign #RegulatoryCompliance #PharmaInsights ClinicalTrials FDAReview PharmaInsights ProtocolDesign RegulatoryCompliance SiteAudit"  
[YouTube Link](https://youtube.com/watch?v=ZDmdZoL71ls)  2026-02-12T16:03Z 82.7K followers, [---] engagements


"Forget the NBA DraftThis Team Just Landed Their Own Victor Wembanyama 🤯 The buzz is real over the incredible new addition to the team: Dora an international medical graduate staff member. The consensus is clearthis hiring move rivals the biggest steals in sports history. Listen as the hosts break down why landing this exceptional talent feels like winning the lottery comparing the potential to securing a generational athlete like Victor Wembanyama for the Spurs. The standard for top-tier talent has just been redefined #MedicalStaff #InternationalMedicalGraduate #HealthcareTalent #Wemby"  
[YouTube Link](https://youtube.com/watch?v=ZVDTSBHexuk)  2026-02-08T19:01Z 71K followers, [---] engagements


"FDA "Rejection" = Next Year's HUGE Buying Window Many anticipated a clear path forward but the market received a less than ideal outcome. This surprising turn of events has unexpectedly gifted the disciplined investor a full extra year. That twelve-month runway provides significant time to strategically load up on assets during any temporary downturns provided one can successfully ignore the surrounding market chatter. The true value here lies in the extended window granted to those playing the long game. #FDA #BiotechInvesting #StockMarket #BuyingTheDip #InvestmentStrategy"  
[YouTube Link](https://youtube.com/watch?v=_AHWoN7_Lao)  2026-02-03T21:03Z 56.5K followers, [---] engagements


"Clinical research associates essentially get their hours arbitraged by the CROs"  
[YouTube Link](https://youtube.com/watch?v=_HTtgRK8MYI)  2026-02-12T16:35Z 82.7K followers, [---] engagements


"Massive Medical Research Fraud CASE Just Blew Up In Miami 🤯 A shocking expos reveals systemic deception in a recent Miami clinical study. Five key sites contributing half the data pool were found to be operating on fabricated patient records and template-copied MRI results across the board. The situation escalated dangerously when an independent auditor faced threats of physical harm during an investigation. The root of this massive deception appears to be a deep-seated conflict of interest linking a CRO executive directly to leadership roles at the compromised research sites. The fallout"  
[YouTube Link](https://youtube.com/watch?v=_nrM0Q-JUMQ)  2026-02-06T18:09Z 56.5K followers, [--] engagements


"FDA agents mingling with reps The undercover truth revealed Imagine the scene: FDA officials walking convention floors engaging sales teams post-launch. A sales representative's moment of truthare they aware of the regulatory tightrope they're walking Discover the fascinating dynamic when the industry meets its watchful eye all while giving a special nod to the reps who inadvertently supply the case studies. #FDA #MedicalSales #RegulatoryAffairs #ConventionLife #PharmaSales ConventionLife FDA MedicalSales PharmaSales RegulatoryAffairs ConventionLife FDA MedicalSales PharmaSales"  
[YouTube Link](https://youtube.com/watch?v=_vWUPck3ObQ)  2026-02-11T20:00Z 75K followers, [---] engagements


"Investor Alert: FDA Audits Hold Market Secrets Savvy investors know the real story isn't just the science; it's who the SEC is watching. Unpacking the critical questions about FDA audit targets and the penalties for failing to report key trial outcomes. A crucial look at regulatory risk that shapes stock performance. #FDA #SEC #StockMarket #InvestingTips #DueDiligence #HealthcareStocks #AuditRisk AuditRisk DueDiligence FDA HealthcareStocks InvestingTips SEC StockMarket AuditRisk DueDiligence FDA HealthcareStocks InvestingTips SEC StockMarket"  
[YouTube Link](https://youtube.com/watch?v=_yBmOtZKzBk)  2026-02-10T19:25Z 75K followers, [---] engagements


"World-Changing Tech: Why They're Holding Back the Future The consensus is emerging: cutting-edge artificial intelligence and staggering leaps in biotechnology are no longer just scientific pursuits; they are fundamental concerns for national security across the globe. Whispers suggest that releasing the full extent of these capabilities immediately would trigger worldwide disruption leading to an unprecedented era of chaos. Someone noted that humanity might already possess the keys to massive transformation but for stability's sake progress is being carefully metered out. What does this"  
[YouTube Link](https://youtube.com/watch?v=a-5hA3L5maw)  2026-02-08T18:10Z 75K followers, [---] engagements


"$AQST Aquestive Therapeutics CRL Dissection With FDA Attorney- FDA Gave Us [--] Free Months AQST and IOVA Biotech Stock Talk"  
[YouTube Link](https://youtube.com/watch?v=a0fsPwjZx4o)  2026-02-05T01:43Z 62.3K followers, [---] engagements


"The Rise of AQST: From $300M to New Heights Reflecting on the impressive journey of AQST this discussion highlights its remarkable growth trajectory and potential for further gains. With market sentiments shifting and analysts predicting even more upside the conversation dives deep into whether AQST can soar to new highs. Discover the insights and share the excitement surrounding this dynamic stock as it continues to make waves in the market. #AQST #StockMarket #Investment #MarketTrends #GrowthStocks AQST GrowthStocks Investment MarketTrends StockMarket AQST GrowthStocks Investment"  
[YouTube Link](https://youtube.com/watch?v=aRT4uORNX_g)  2025-11-15T23:09Z 71K followers, [---] engagements


"Ever wondered what the CRA lifestyle is really like 🌍✈ Explore the dynamic world of Clinical Research Associates and the unique challenges they face on the road. This engaging video delves into the reality of constant travel unexpected delays and the strategies CRAs use to balance work and life. With insights into payment structures and a glimpse into mentorship opportunities this is a must-watch for anyone curious about the intricacies of the CRA role. Buckle up for an eye-opening journey that reveals just how demandingand rewardingit can be to be a CRA #CRA #ClinicalResearch"  
[YouTube Link](https://youtube.com/watch?v=aelhC9qLwY8)  2025-03-20T16:15Z 75K followers, [---] engagements


"The $10B question: Are these labs actually following the rules A massive industry is thriving but its foundation rests on a single technicality: Are these 'lab-developed tests' truly just that or something far more regulated Observers are asking if this multibillion-dollar operation masquerades as something minor. The lines blur between a standard lab service a wellness offering and an actual medical device subject to intense scrutiny and inspection. The stakes are high when the difference could mean FDA oversight. A fascinating deep dive into where the regulations actually apply. #regulation"  
[YouTube Link](https://youtube.com/watch?v=ccwEfxNZF6A)  2026-02-09T20:45Z 72.5K followers, [--] engagements


"What Does A Clinical Trial Assistant (CTA) Typically Do At A Contract Research Organization (CRO) The University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/ Text Me: (949) 415-6256 My podcast is Random Musings From The Clinical Trials Guru Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/dp/1090349521/. Text "guru" to 855-942-5288 to join VIP list My blog: http://www.TheClinicalTrialsGuru.com My CRO and Site Network: http://www.DSCScro.com My CRA Academy: http://www.TheCRAacademy.com My CRC Academy:"  
[YouTube Link](https://youtube.com/watch?v=cxBiTtTrK1g)  2022-03-18T16:33Z 60.8K followers, 11.7K engagements


"The Unstoppable Rise: Is Your Career Field AI-Proof This compelling segment explores the accelerating integration of artificial intelligence across various industries from autonomous vehicles to automated restaurant service. The discussion pivots to the significant looming impact on professional sectors like clinical research. Witness the unsettling reality as technology reshapes the employment landscapea crucial perspective from a leading mind in the tech sphere on where the next wave of automation will land. #AI #Automation #FutureOfWork #TechTrends #ClinicalResearch #JobDisruption"  
[YouTube Link](https://youtube.com/watch?v=dftOt2ysA40)  2026-02-09T21:24Z 75K followers, [--] engagements


"Site Networks are the NEW CRO An insider's shocking confession on AI and the 'soul' of research 🤯 A startling industry revelation surfaces after a post went viral: an employee from a major site network confirmed a brutal internal reality. The sentiment suggests that the aggressive adoption of Artificial Intelligence is leading to massive layoffs and more alarmingly the systematic eradication of the human elementthe very 'soul' of clinical research operations. This situation forces a profound consideration for every stakeholder: At what point does efficiency become cultural destruction and"  
[YouTube Link](https://youtube.com/watch?v=em7TUzJrfAI)  2026-02-07T18:00Z 62.3K followers, [---] engagements


"Clinical Research Site Level Roles You Can Do Completely Remotely (While They Still Last) My substack FREE: https://substack.com/@dansfera1r=27gh4e&utm_medium=ios&utm_source=profile Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK"  
[YouTube Link](https://youtube.com/watch?v=fVjQ9RDyAwI)  2026-02-12T23:56Z 86.2K followers, [----] engagements


"Six Months to FDA Decision for Anaphylaxis Treatment A crucial update surfaces regarding a new NDA resubmission expected around September. Observers are noting the standard six-month review period leading up to next February. Interestingly there's precedent suggesting a faster turnaround as one organization secured approval in just four months. This accelerated path is significant given the growing concerns surrounding anaphylactic reactions and the potential for an Expanded Access pathway to address these urgent public health needs. #FDA #Approval #Drug #Development #Anaphylaxis #Medical"  
[YouTube Link](https://youtube.com/watch?v=fXwON9ttbiU)  2026-02-06T22:42Z 75K followers, [--] engagements


"Ozempic: Approved Drug or Wild Claims The Fine Line. An outside observer examines the fine print surrounding Ozempic's uses. When a drug is known for diabetes and weight loss what happens when claims drift into territory like cancer treatment or addiction areas still under intense study The distinction between established evidence and preliminary research is what dictates whether a prescription medication's promotion crosses into legally risky unproven territory. This segment cuts through the noise to reveal the crucial difference. #Ozempic #FDA #DrugRegulation #Pharmaceuticals"  
[YouTube Link](https://youtube.com/watch?v=fbipbA1Tekk)  2026-02-10T01:00Z 75K followers, [---] engagements


"When the CRO Executive is also the Site Advisor. You won't believe the web of connections being. A startling look into the interconnected web where top Contract Research Organization leadership simultaneously holds advisory roles for research sites. This consolidation particularly with Institutional Review Boards owning significant tech stacks and even research facilities raises serious questions about governance and ethical independence. Observing how these deep-seated relationships separateor if they can be separated at allis crucial for understanding the current landscape of clinical"  
[YouTube Link](https://youtube.com/watch?v=fitMCzRGOF0)  2026-02-07T23:18Z 62.3K followers, [--] engagements


"State AGs vs. Doctors: It's about the dosage Legal eagles are focusing their sights not just on prescribing medications for unapproved uses but on a more subtle maneuver: altering the established dosage. Observers note that changing the dose from what the FDA approved is becoming a significant point of vulnerability for physicians potentially inviting scrutiny from state regulators and malpractice suits. This perspective unpacks where the real regulatory 'safe harbor' might have vanished. #DrugSafety #MedicalLaw #OffLabel #DoctorLiability #HealthcareRegulation #StateAG DoctorLiability"  
[YouTube Link](https://youtube.com/watch?v=frzm1IZmLzA)  2026-02-10T23:07Z 75K followers, [---] engagements


"Why Working at a CRO Might Not Be What You Think 🤔 Exploring the hidden truths of clinical research this insightful short dives into the stabilityor lack thereofof working at a large CRO. Discover why contract research organizations are often the first to make difficult decisions like outsourcing and layoffs. While they can serve as a launching pad for your career they come with a level of instability that might surprise many. Learn more about the landscape of clinical research and where the real security lies among sponsors sites and tech vendors. This is an essential watch for anyone in"  
[YouTube Link](https://youtube.com/watch?v=h6T5qTtIe7M)  2024-11-12T18:52Z 75K followers, [---] engagements


"90% Approval Rate The FDA's Secret Focus on User Error. A fascinating look at what truly secures regulatory clearance. The focus shifts dramatically when medication error prevention or DEMIPA becomes the chief concern. It turns out the FDA places significant weight not on achieving flawless performance studies but on ensuring packaging won't cause dangerous mistakes even if a user is struggling in a near-panic state. This priority explains why resubmission approval rates climb to an astonishing [--] to [--] percent in these specific cases mirroring the direct parallels observed with NEFI."  
[YouTube Link](https://youtube.com/watch?v=i6qBu1EUnUA)  2026-02-05T17:43Z 56.5K followers, [--] engagements


"MAJOR Rule Change Off-Label Prescriptions Under Fire An incredible legal development is shaking up medical practice right now. Certain health information regarding transgender youth is now a point of intense focus for the administration leading to scrutiny over how doctors have historically prescribed treatments "off-label." Even seasoned legal experts may not grasp the full scope of this cutting-edge shift in regulatory oversight. This situation demands attention from anyone involved in healthcare policy and patient advocacy. #legalshift #medicalpolicy #doctorupdate #transhealth"  
[YouTube Link](https://youtube.com/watch?v=inqWD7xDch8)  2026-02-09T17:44Z 75K followers, [---] engagements


"Are Clinical Trial Sites Facing Extinction Digital Twins Could Change EVERYTHING for Pharma 🤯 The notion that major pharmaceutical players even revered ones like Eli Lilly could soon receive regulatory clearance to sidestep traditional Contract Research Organizations (CROs) and physical testing locations for certain studies is a seismic thought. This perspective delves into a scenario where empowering drug sponsors with sophisticated digital twin simulation technology renders the need for on-site patient recruitment obsolete. Consider the implications when the familiar process of negotiating"  
[YouTube Link](https://youtube.com/watch?v=jOPNmEWXI5k)  2026-02-08T22:43Z 75K followers, [--] engagements


"The $7 Stock Trading at CASH Value (26 Days Left) - $VNDA - Vanda Pharmaceuticals - My Swing Trade My substack FREE: https://substack.com/@dansfera1r=27gh4e&utm_medium=ios&utm_source=profile Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK"  
[YouTube Link](https://youtube.com/watch?v=j_bX9-JL8Pw)  2026-01-26T19:20Z 82.7K followers, [--] engagements


"$800 Million Bets 🤯 What's driving the massive private equity rush to acquire clinical research. The M&A super cycle in clinical research shows no signs of stopping. Witness the staggering figureslike an $800 million deal for a 30-site networkthat lured Private Equity into this specialized sector. Even with a slight pause industry titans like Velocity continue to expand their footprint across hundreds of research locations. This clip unpacks the underlying forces fueling this aggressive consolidation among CROs and investors. A major shift is underway in how clinical trials are being"  
[YouTube Link](https://youtube.com/watch?v=jno-m1AQt_w)  2026-02-09T23:09Z 72.5K followers, [--] engagements


"FDA's REAL priority: Lives over your portfolio gains. The real motivation behind prolonged drug approval processes is laid bare. When regulators choose caution to ensure maximum patient benefit the concerns of market traders and portfolio performance fade into the background. Listen as this analysis cuts through the noise explaining why the FDA's mandate fundamentally separates it from Wall Street's expectations even while acknowledging the high probability of certain study outcomes. #FDA #DrugApproval #Biotech #StockMarket #PatientSafety #PharmaNews #Investing #ClinicalTrials Biotech"  
[YouTube Link](https://youtube.com/watch?v=jzRlxHUIfIo)  2026-02-07T16:47Z 62.3K followers, [--] engagements


"The Psychedelic Merger: Inside AtaiBeckley's Rise ($ATAI Stock) Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorr Text "guru" to 855-942-5288 to join VIP list My blog:"  
[YouTube Link](https://youtube.com/watch?v=l0I7RE5Kmm8)  2025-11-20T05:42Z 75K followers, [---] engagements


"Discipline beats the dips. See the truth behind biotech risk The essential mindset for navigating small-cap biotech investment reveals itself. Smart money understands that true discipline means looking past the constant chatter about dilution risk. Focusing strictly on tangible results is the secret saucea crucial perspective for anyone watching this sector. #investment #discipline #biotech #stocks #market #noise #small #cap #investing #investor #psychology #stock #market #tips biotech cap discipline investing investment investor market noise psychology small stock stocks tips biotech cap"  
[YouTube Link](https://youtube.com/watch?v=l1V27qKw_uo)  2026-02-05T22:36Z 62.3K followers, [--] engagements


"Is the needle officially DEAD 🤯 See the wild future of blood collection Experts are debating whether the current often uncomfortable method of blood collection has an expiration date. Imagine a future where a machine utilizes advanced technologya 'laser eye'to precisely locate a vein and collect a sample before you even leave the waiting area. This clip explores the stunning timeline for when such science fiction could become the medical standard suggesting the change might be closer than we think perhaps even within the next decade. #futuristicmedicine #medicaltechnology #blooddraw"  
[YouTube Link](https://youtube.com/watch?v=l83uQEEqzTs)  2026-02-09T01:35Z 75K followers, [---] engagements


"Nine Months of Market Calm DCA Strategy Revealed Experts are mapping out the next nine months as a period of predictable range-bound trading. Learn the measured approach suggested for navigating these stable waters involving strategic dollar-cost averaging to potentially capitalize on movements between the mid-two and seven price points. A fascinating look at holding steady through the expected sideways action. #MarketAnalysis #DollarCostAveraging #RangeTrading #InvestmentStrategy #TradingTips DollarCostAveraging InvestmentStrategy MarketAnalysis RangeTrading TradingTips DollarCostAveraging"  
[YouTube Link](https://youtube.com/watch?v=lI_uLVqvCkg)  2026-02-06T18:40Z 71K followers, [---] engagements


"75 studies for ONE drug The truth about pharma trials is wild Someone just dropped a bombshell about pharmaceutical testing timelines. Is it one study or a mountain of evidence Unpacking the difference between the single pivotal trial and the sheer volume of research actually needed to get a life-saving treatment to market is a serious eye-opener. The numbers might shock you. #DrugApproval #PharmaResearch #ClinicalTrials #ScienceFacts #HealthcareTruth #DrugDevelopment #MedicalScience ClinicalTrials DrugApproval DrugDevelopment HealthcareTruth MedicalScience PharmaResearch ScienceFacts"  
[YouTube Link](https://youtube.com/watch?v=mIE1B3euC5I)  2026-02-08T22:32Z 70.1K followers, [--] engagements


"FDA's Crackdown: Advertising Violations Hit Record Highs The regulatory landscape is heating up Reports indicate a significant surge in advertising violations and CMC deficiencies reaching unprecedented levels. A deep dive reveals that insufficient site monitoring particularly concerning BIMO is emerging as the primary concern leading to numerous [---] observations and stern warning letters for research facilities. This critical trend is slated for serious discussion at the upcoming SOS event. #FDA #AdvertisingCompliance #RegulatoryAffairs #ClinicalTrials #Monitoring #BIMO #WarningLetter"  
[YouTube Link](https://youtube.com/watch?v=m_Oi4JlQwMg)  2026-02-10T17:08Z 75K followers, [---] engagements


"State lines mean nothing to medical data requests 🤯 Revelations about states demanding patient data from cross-state medical tourism particularly concerning sensitive procedures. The question of jurisdiction over personal health records when crossing state borders is being fiercely tested. A look into the implications for medical privacy across the United States. #MedicalPrivacy #StateLaw #Healthcare #DataSecurity #AbortionAccess #Jurisdiction #USPolitics AbortionAccess DataSecurity Healthcare Jurisdiction MedicalPrivacy StateLaw USPolitics AbortionAccess DataSecurity Healthcare Jurisdiction"  
[YouTube Link](https://youtube.com/watch?v=mtfMK4a4EII)  2026-02-09T23:56Z 75K followers, [--] engagements


"FDA [---] = Drug Death Sentence The surprising truth revealed. Experts debate the true weight of an FDA Form [---] when paired with pivotal trial data. While regulations suggest a handful of key studies suffice the reality for drug approval involves an astonishing average of around [--] trials. Unpacking the nuance between regulatory minimums and the practical hurdles in getting a new medicine to market. This clip offers a fascinating glimpse behind the curtain of pharmaceutical approvals. #pharma #FDA #drugapproval #clinicaltrials #medicalresearch #drugdevelopment #483form #biotech 483form FDA"  
[YouTube Link](https://youtube.com/watch?v=mwUAtfC0Yko)  2026-02-09T16:37Z 72.5K followers, [---] engagements


"$AQST FDA NOTIFICATION - Aquestive Therapeutics - MASSIVE BUY OPPORTUNITY IF IM RIGHT My substack FREE: https://substack.com/@dansfera1r=27gh4e&utm_medium=ios&utm_source=profile Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK"  
[YouTube Link](https://youtube.com/watch?v=n-vCgwXBtLU)  2026-01-10T18:45Z 62.3K followers, [---] engagements


"How to Sell Your Clinical Research Site Without Killing the Deal Hannah's LinkedIn: https://www.linkedin.com/in/hannahkempski/ My substack FREE: https://substack.com/@dansfera1r=27gh4e&utm_medium=ios&utm_source=profile Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK"  
[YouTube Link](https://youtube.com/watch?v=o3puVIKgteM)  2026-02-09T18:50Z 75K followers, [---] engagements


"🔬 Latest Biotech Trial Results: Unprecedented Efficacy in Refractory NSCLC $IOVA stock Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorr Text "guru" to 855-942-5288 to join VIP list My blog:"  
[YouTube Link](https://youtube.com/watch?v=pBGbLILfyc0)  2025-11-04T00:02Z 62.3K followers, [---] engagements


"Biotech's Ticking Clock: Is Your Company Ready for the [----] Extinction Line A stark warning echoes through the life sciences sector regarding the next few years. A critical window is suggested to be closing rapidly with [----] looming as the major inflection point. The viewpoint shared is clear: organizations that have not achieved significant differentiation or figured out how to scale effectively face a grim forecast. This could mean being driven out of business being acquired for very little return or simply fading into market irrelevance. This perspective demands immediate strategic focus"  
[YouTube Link](https://youtube.com/watch?v=q69hZ5vbCSA)  2026-02-08T00:42Z 75K followers, [---] engagements


"AI vs. 200+ FDA Warning Letters: Game Changer Witness the power shift as leading large language modelsClaude Grok and Geminiare put to the ultimate compliance test. Analyzing hundreds of FDA warning letters once a grueling manual task is now being streamlined by artificial intelligence. See the surprising implications when massive volumes of regulatory documents are processed simultaneously. A major shift for compliance professionals #FDA #WarningLetters #AIAnalysis #RegulatoryCompliance #LLM #PharmaTech #Grok #Gemini #ClaudeAI #Compliance AIAnalysis ClaudeAI Compliance FDA Gemini Grok LLM"  
[YouTube Link](https://youtube.com/watch?v=q9R9BndeYfU)  2026-02-09T22:00Z 72.5K followers, [--] engagements


"HIMS: Bounce Back or Dead Cat Dive Observers are closely watching the recent dip in HIMS. Many believe the sharp decline is overdone anticipating a significant rally very soonperhaps even doubling from current levels. The key question remains: is this dip a temporary correction or the start of a prolonged freefall With serious DOJ and legal clouds hanging over the company the market sentiment is saturated with fear making any quick resolution unlikely. Where does the real value lie now #stockmarket #investment #HIMS #trading #technicalanalysis #marketfear #valuation HIMS investment marketfear"  
[YouTube Link](https://youtube.com/watch?v=qlHKZo97uf4)  2026-02-11T20:19Z 75K followers, [---] engagements


"The FDA's *real* power exposed See the [--] limits. Someone uncovered the startlingly short list of responsibilities the Food and Drug Administration actually holds regarding pharmaceuticals. It boils down to just four pillars: safety efficacy and avoiding adulteration or misbranding. Anything outside those specific boundaries seems to fall outside their watch. A crucial perspective for anyone concerned about drug oversight. #FDA #DrugSafety #Pharmaceuticals #Regulation #GovernmentOversight #HealthPolicy DrugSafety FDA GovernmentOversight HealthPolicy Pharmaceuticals Regulation DrugSafety FDA"  
[YouTube Link](https://youtube.com/watch?v=spCuSi1tplQ)  2026-02-10T20:20Z 75K followers, [---] engagements


"What You Need to Know About The ACRP Association for Clinical Research Professionals Certifications My substack FREE: https://substack.com/@dansfera1r=27gh4e&utm_medium=ios&utm_source=profile Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK"  
[YouTube Link](https://youtube.com/watch?v=tjdBvKY3q_4)  2026-02-06T18:57Z 56.5K followers, [---] engagements


"STOP GUESSING: The Biotech Buyout Formula to Find a $2.50 Stock Worth $22 ($IOVA Case Study) Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorr Text "guru" to 855-942-5288 to join VIP list My blog:"  
[YouTube Link](https://youtube.com/watch?v=vCkPphB680o)  2025-11-17T18:33Z 75K followers, [---] engagements


"FDA Secret Risk Analysis: What They Don't Tell You. The stakes are astronomical when a drug designed for a major or rare condition enters a pivotal study. Imagine the tension: a trial where every participant shows an adverse event or conversely where none do. Observers examine the tightrope walk knowing that one of only three sites might determine the fate of this medication. The crucial question remains: how does the governing body weigh these life-altering variables The agency's precise list of considered risks and how they are actually measured remains completely undisclosed. A truly"  
[YouTube Link](https://youtube.com/watch?v=w0xbHuWtF00)  2026-02-09T19:24Z 75K followers, [---] engagements


"Is your research job on the chopping block AI is coming A stark look at which clinical research roles face imminent disruption from automation. Discover the surprising tasks now deemed obsolete and the critical human-centric skills that offer sanctuary from the screen-based takeover. See where the true career longevity lies for CRAs and site staff amidst the rise of intelligent systems. #AIinClinicalResearch #CRACareer #FutureOfWork #ClinicalTrials #JobSecurity #ResearchAutomation AIinClinicalResearch CRACareer ClinicalTrials FutureOfWork JobSecurity ResearchAutomation AIinClinicalResearch"  
[YouTube Link](https://youtube.com/watch?v=x7pmXk3ZLPA)  2026-02-12T18:51Z 82.7K followers, [--] engagements


"Biotech's nightmare Fed Chairman's actions explained. The market shockwaves are clear: a less aggressive Federal Reserve stance is putting serious pressure on the biotech landscape. Discover why assets like silver and Bitcoin have tumbled and how this high-interest environment suffocates an industry built on future potential. An expert predicts a challenging range-bound year for the entire sector. #Biotech #FederalReserve #InterestRates #StockMarket #Investing #BiotechStocks #MarketAnalysis Biotech BiotechStocks FederalReserve InterestRates Investing MarketAnalysis StockMarket Biotech"  
[YouTube Link](https://youtube.com/watch?v=xhbzhS652AI)  2026-02-07T19:20Z 62.3K followers, [---] engagements


"30 Years From Now: Is This Career DEAD 🤯 The Future of Research Sites Debated A fascinating glimpse into the future of scientific inquiry. The question hangs in the air: when observers look [--] years ahead to [----] do the current structures of research sites still hold up Hear the candid slightly apprehensive debate on career longevity and the evolution of scientific discovery. It's a deep dive into what might be possible and what might become obsolete for those dedicated to the lab. #researchfuture #sciencecareer #innovation #futureofwork #lablife #technology #speculation #2056 2056"  
[YouTube Link](https://youtube.com/watch?v=y320aqMiDV4)  2026-02-10T00:04Z 75K followers, [----] engagements


"FDA Regulatory Pathways for Medical Devices - Differences Between 510k PMA and De Novo My substack FREE: https://substack.com/@dansfera1r=27gh4e&utm_medium=ios&utm_source=profile Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK"  
[YouTube Link](https://youtube.com/watch?v=zIry6SXtjzE)  2026-01-30T20:00Z 75K followers, [---] engagements


"$IOVA Due Diligence and EMA Rejection Deep Dive Iovance Biotherapeutics Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorr Text "guru" to 855-942-5288 to join VIP list My blog:"  
[YouTube Link](https://youtube.com/watch?v=zOeI0hXhSbA)  2025-10-30T05:57Z 75K followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

@dansfera Avatar @dansfera Dan Sfera

Dan Sfera posts on YouTube about ai, future, fda, $aqst the most. They currently have [------] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.

Engagements: [-----] #

Engagements Line Chart

  • [--] Week [------] +101%
  • [--] Month [-------] +103%
  • [--] Months [-------] +66%
  • [--] Year [---------] +826%

Mentions: [--] #

Mentions Line Chart

  • [--] Week [--] -5%
  • [--] Month [---] -41%
  • [--] Months [-----] +113%
  • [--] Year [-----] +837%

Followers: [------] #

Followers Line Chart

  • [--] Week [------] +46%
  • [--] Month [------] +103%
  • [--] Months [------] +109%
  • [--] Year [------] +119%

CreatorRank: [-------] #

CreatorRank Line Chart

Social Influence

Social category influence finance 28.78% stocks 5.76% countries 2.16% technology brands 0.72% cryptocurrencies 0.72%

Social topic influence ai 8.63%, future 7.19%, fda 7.19%, $aqst 6.47%, investment 6.47%, $iova 5.76%, market 5.04%, $6753t #1450, food 4.32%, health 4.32%

Top accounts mentioned or mentioned by @dansfera1r27gh4eutmmediumiosutmsourceprofile

Top assets mentioned Iovance Biotherapeutics, Inc. Common Stock (IOVA) Atai Life Sciences B.V. (ATAI) ARS Pharmaceuticals, Inc. (SPRY) Intellia Therapeutics, Inc (NTLA) Prime Medicine, Inc. (PRME)

Top Social Posts

Top posts by engagements in the last [--] hours

"FDA Says NO to Life-Saving Strip User Error This development surrounding Equestiv Therapeutics' innovative epinephrine film is a major eye-opener. Despite the drug's potential the FDA issued a Complete Response Letter reportedly due to critical patient non-compliance. It seems the issue wasn't the science behind the life-saving strip but how people were using itchewing spitting or placing it incorrectly on the tongue. A stark reminder that even the simplest delivery systems rely on perfect human execution. The implications for future rapid-response medical devices are significant."
YouTube Link 2026-02-12T20:11Z 85.9K followers, [--] engagements

"FDA Escalation: Case Lands at the DOJ When the head of the Food and Drug Administration actively directs a matter to the Department of Justice the implications are massive. This isn't a suggestion; it's a demand for investigation and action. Discover the real-world meaning behind this high-stakes referral and why observers are certain that significant developments are now inevitable. The outcome is the only question left unanswered. #FDA #DOJ #GovernmentAction #RegulatoryUpdate #LegalNews #Investigation DOJ FDA GovernmentAction Investigation LegalNews RegulatoryUpdate DOJ FDA GovernmentAction"
YouTube Link 2026-02-14T22:11Z 86.2K followers, [--] engagements

"Aquestive Therapeutics $AQST Deep Dive With Biotech Scanner Biotech Scanner X: https://x.com/BIOTECHSCANNER CRIO: http://www.clinicalresearch.io Inato: https://go.inato.com/3VnSro6 Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 My podcast is Random Musings From The Clinical Trials Guru Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorr Text "guru" to 855-942-5288 to join VIP"
YouTube Link 2024-07-24T17:52Z 85.9K followers, [---] engagements

"Oncology Clinical Trials Crash Course For Clinical Researchers and Biotech Investors Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorr Text "guru" to 855-942-5288 to join VIP list My blog:"
YouTube Link 2025-11-18T12:00Z 86.2K followers, [----] engagements

"Unlocking the Future of Mental Health: DMT for Depression Explore the groundbreaking developments in mental health treatments as companies shift focus from traditional methods to more innovative solutions. The new intranasal DMT therapy is paving the way for effective options for treatment-resistant depression. With the recent release of promising phase 2B results the conversation around DMT as a potential game-changer in depression treatment continues to gain momentum. Insights from industry experts hint at a future where depression could be tackled in new ways never thought possible. Get"
YouTube Link 2025-09-02T13:40Z 85.6K followers, [----] engagements

"This HIMS price is too high. Wait for the drop A frank look at the HIMS situation reveals a compelling argument for patience. The commentator suggests the current valuation is inflated and a further dip is likely before any real buying opportunity arises. Despite humorous disclaimers about their own investing success the underlying bearish sentiment is unmistakable. That quick bounce just might not be happening. #HIMSstock #StockMarket #Investing #Bearish #PricePrediction #MarketAnalysis Bearish HIMSstock Investing MarketAnalysis PricePrediction StockMarket Bearish HIMSstock Investing"
YouTube Link 2026-02-14T19:37Z 86.2K followers, [--] engagements

"Clinical Research Coordinator Interview Questions: How To Be Prepared LICR Link: https://www.linkedin.com/posts/latinos-in-clinical-research_latinosinclinicalresearch-diversityinclinicalresearch-activity-6960385322547343360-1lZiutm_source=linkedin_share&utm_medium=member_desktop_web The University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/ Text Me: (949) 415-6256 My podcast is Random Musings From The Clinical Trials Guru Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/dp/1090349521/. Text "guru" to"
YouTube Link 2022-08-08T19:51Z 82.7K followers, 47K engagements

"AI can't see this. Real human foresight in clinical trials Witness the critical skill separating seasoned clinical operations experts from nascent technology. A seasoned CRA's ability to intuitively pinpoint flaws in study designwhere patients or sites are most likely to stumblestems from deep multi-faceted fluency across the entire clinical landscape. That immediate pattern-recognition insight remains a uniquely human advantage over current artificial intelligence capabilities. #clinicalresearch #CRA #clinicaloperations #AIvsHuman #drugdevelopment #clinicaltrials #designintelligence"
YouTube Link 2026-02-14T00:54Z 86.2K followers, [---] engagements

"CRO Trend Shocker: 5+ Years Experience is NOW a Liability The prevailing wisdom in clinical research monitoring just got a massive reality check. A surprising shift is hitting hiring practices where longevity in the fieldspecifically over five years of monitoring experienceis strangely becoming a drawback. Recruiters are reportedly seeking that "Goldilocks zone" of just two to three years on the resume. Discover the bizarre industry pivot that could redefine career paths for seasoned professionals. #CRO #ClinicalResearch #ClinicalTrials #Monitoring #CareerChange #JobMarket #CROJobs CRO"
YouTube Link 2026-02-08T21:36Z 85.9K followers, [--] engagements

"Stop Overthinking Your Trades Being Too Smart Can Cost You. A fascinating perspective on market timing suggests that deep expertise can actually sabotage potential profits. When one understands the nuances too well they might enter a position before mass adoption only to panic-sell during the slow initial phase. The paradox revealed here is that sometimes a lack of total knowledge allows an investor to hold on just long enough for the crowd to catch up leading to the real payday. A cautionary tale for the self-proclaimed experts. #investing #stockmarket #finance #mindset #tradingpsychology"
YouTube Link 2026-02-12T19:12Z 85.9K followers, [--] engagements

"Biotech Risks & Why This AI Mogul's Name Spooks Them. A deep dive into the shaky ground beneath certain biotech investments. Unpacking why relying on outsourced trials especially when certain high-profile figures are involved raises serious eyebrows for astute observers. An interesting perspective on where the real risks hide in the startup funding world. #BiotechInvesting #SamAltman #ChatGPT #CRO #StartupRisk #InvestmentAnalysis #TechSkeptic BiotechInvesting CRO ChatGPT InvestmentAnalysis SamAltman StartupRisk TechSkeptic BiotechInvesting CRO ChatGPT InvestmentAnalysis SamAltman StartupRisk"
YouTube Link 2026-02-13T00:03Z 86.2K followers, [---] engagements

"Site Networks: PE's 10X Return Dream or Imminent Pop The big question surrounding private equity's massive outlay for digital site networks revolves entirely around the exit. With demands for 7X or even 10X returns the entire model hinges on someone else eventually buying in at an even higher price. Analysts are watching closely to see if consolidators like the firms snapping up multi-million dollar portfolios represent the final stop for these assets. The sustainability of this high-stakes game is seriously being tested. #PrivateEquity #DigitalAssets #InvestmentBubble #WebsiteAcquisition"
YouTube Link 2026-02-14T21:16Z 86.2K followers, [--] engagements

"FDA Snag $100M Blunder Avoidable Witness the staggering fallout when site-level oversight fails. A single seemingly minor monitoring mistake has the power to derail a critical drug application translating directly into over one hundred million dollars in lost revenue and a year's delay for market access. The case of Equestiv Therapeutics and their innovative anaphylaxis treatment serves as a stark perhaps completely preventable warning to the entire pharmaceutical sector regarding regulatory adherence. #DrugApproval #FDA #Pharma #ClinicalTrials #SiteMonitoring #MedTech #Biotech"
YouTube Link 2026-02-12T23:06Z 86.2K followers, [--] engagements

"CROs: Are they really saving you money The hidden profit trap revealed A fascinating look into the traditional Clinical Research Organization (CRO) model reveals a potential disconnect. One expert unpacks how those seemingly beneficial vendor relationships were often leveraged for the CRO's profit margin not the sponsor's bottom line. Discover the shift toward functional sourcing that's changing the game for trial budgets. #ClinicalTrials #CRO #HealthcareFinance #ClinicalResearch #Pharma CRO ClinicalResearch ClinicalTrials HealthcareFinance Pharma CRO ClinicalResearch ClinicalTrials"
YouTube Link 2026-02-13T21:54Z 86.2K followers, [--] engagements

"Clinical Research Career Paths: PhDs and Assistants My substack FREE: https://substack.com/@dansfera1r=27gh4e&utm_medium=ios&utm_source=profile Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorr Text"
YouTube Link 2026-02-03T12:15Z 86.2K followers, 26.5K engagements

"David vs. Goliath in the legal world Can they catch up The conversation pivots to a fascinating showdown: a smaller legal entity facing off against a true industry behemoth King & Spalding reportedly pulling in billions annually. The sheer scale difference is staggering yet the ambition displayed is even bigger. Witness the sheer audacity of the challenger aiming to eclipse a $5 billion revenue giant in just a few more podcast appearances. A masterclass in competitive spirit. #lawfirm #legalbattle #davidvsgoliath #law #kingandspalding #smallbusiness #ambition ambition davidvsgoliath"
YouTube Link 2026-02-12T19:58Z 86.2K followers, [--] engagements

"Miracle Cure Killed by Paperwork The $10M Tragedy. Witness the stunning corporate autopsy of a near-miracle pharmaceutical. Tens of millions poured into developing treatments that could change millions of livesonly for the entire venture to collapse. The reason A seemingly minor oversight in documenting patient feedback at scale. This story reveals a crucial often overlooked bottleneck in bringing truly life-altering therapies to the masses. It's a cautionary tale about how administrative details can eclipse scientific breakthrough. #DrugDevelopment #PharmaFailures #ClinicalTrials #Biotech"
YouTube Link 2026-02-14T00:16Z 86.2K followers, [---] engagements

"GLP-1 Ad Wars: The Stock Market Showdown Revealed An interesting observation surfaces: the marketing focus isn't on a specific GLP-1 but on the advertiser itself seemingly drawing a sharp contrast with HIMS. Discover the subtle yet powerful shift in how pharmaceutical growth is being positioned and what this tactic might mean for the stock charts especially as one competitor seems to be taking a hit. A fascinating look at market positioning versus product promotion. #GLP1 #HIMS #PharmaMarket #StockAnalysis #HealthcareMarketing #InvestmentStrategy GLP1 HIMS HealthcareMarketing"
YouTube Link 2026-02-15T00:28Z 86.2K followers, [---] engagements

"What Is A Clinical Research Coordinator and What Do They Do The University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/ Text Me: (949) 415-6256 My podcast is Random Musings From The Clinical Trials Guru Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/dp/1090349521/. Text "guru" to 855-942-5288 to join VIP list My blog: http://www.TheClinicalTrialsGuru.com My CRO and Site Network: http://www.DSCScro.com My CRA Academy: http://www.TheCRAacademy.com My CRC Academy: http://www.TheCRCacademy.com Latinos In"
YouTube Link 2022-06-21T03:27Z 85.9K followers, 40.5K engagements

"The Only Crash Course To Clinical Research Youll Ever Need (full [--] hour OFFICIAL video) The Only Comprehensive Guide To Clinical Research Youll Ever Need (full [--] hour crash course) v.2019 (Make sure to watch in 1080p to avoid the lip sync lag) GET THE BOOK https://www.amazon.com/dp/1090349521/ref=mp_s_a_1_2crid=C7PR8LO0E2FC&keywords=the+comprehensive+guide+to+clinical+research&qid=1555945352&s=gateway&sprefix=the+comprehensive+guide+to+clinica&sr=8-2 Join this channel to get access to perks: https://www.youtube.com/channel/UCvw9kVKHEyAlZPZ6ZuOd2VA/join Text Me: (949) 415-6256 My podcast is"
YouTube Link 2019-03-05T22:44Z 86.2K followers, 433.3K engagements

"The American Pharma Machine is about to get a serious turbocharge 🚀 A fascinating look into the strategic shift within US drug regulation. The pressure is mounting on the FDA to streamline the initial stages of drug developmentspecifically Phase [--] studies and IND approvalsas global competitors particularly China gain significant ground. What does this mean for research sites on the ground Experts suggest this move is designed to create an easier gateway for sponsors potentially leading to a significant uptick in clinical trial activity across the board. This is a major pivot in global"
YouTube Link 2026-02-08T16:39Z 71K followers, [---] engagements

"Some Biotech Stock Due Diligence - $AQST $IOVA With Biotechscanner and a bonus pick by me Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorr Text "guru" to 855-942-5288 to join VIP list My blog:"
YouTube Link 2025-08-24T17:26Z 62.3K followers, [---] engagements

"Thermo Fisher Buys PPD: More Clinical Research Consolidation and Long Term Implications Thermo Fisher Buys PPD: More Clinical Research Consolidation and Long Term Implications"
YouTube Link 2021-04-15T18:42Z 75K followers, [----] engagements

"Telehealth Giant's $4B Cap: Worth the Hype or DOJ Risk Observers are seriously questioning whether the leading telemedicine platform truly warrants its staggering $4 billion valuation. Is being the biggest enough to justify the price tag Experts suggest a market-cap comparison with rivals might be necessary to find an answer. Furthermore the shadow of the Department of Justice looms large prompting speculation that this industry behemoth might need to strategically conserve resources for upcoming challenges. A fascinating look at big tech's market reality. #Telemedicine #MarketCap #Valuation"
YouTube Link 2026-02-12T18:04Z 82.7K followers, [---] engagements

"7-Eleven vs. Your Doctor: The Placement Showdown Revealed. Corporations are reportedly pushing for studies that compare haphazard consumer placement of certain items against expert application. The ultimate goal appears to be clearing the path for widespread retail availability arguing that even if you grab it off the wrong shelf at a convenience store the outcome is essentially identical to advice given by a healthcare professional. That's a major shift in how self-care products might be sold. #OTC #retailstrategy #healthcare #consumerstudy #7eleven #pharmacy 7eleven OTC consumerstudy"
YouTube Link 2026-02-07T21:51Z 75K followers, [---] engagements

"Biotech buyout rumors Wait for the dip not the hype. After years watching this biotech cycle an interesting pattern emerges around buyout speculation. The reality A "sell the news" event is highly probable meaning rushing in on buyout chatter could be a costly mistake. Observing this from the sidelines reveals a potential entry point after the initial euphoria fades not during. The long-term holder's perspective on when a true acquisition might actually become de-risked is surprisingly cautious. #Biotech #StockMarket #Investing #Buyout #StockStrategy #Trading Biotech Buyout Investing"
YouTube Link 2026-02-07T22:48Z 71K followers, [--] engagements

"Stop Dragging Your Feet Is Your Business Ready for the 'Instant' Economy The standard for operations has fundamentally shifted. What was acceptable in data processing just a few years agoa multi-day turnaroundis now an instant requirement from major players. This clip starkly illustrates the competitive pressure facing any network or business that refuses to embrace the latest technology setting the stage where yesterday's efficiency is today's disqualifier. It's a crucial peek into the new baseline for survival in a market that only rewards immediacy. #BusinessTrends #SpeedOfBusiness"
YouTube Link 2026-02-09T17:57Z 75K followers, [---] engagements

"$NTLA $PRME & Beyond: Why These CRISPR Stocks Could Be HUGE Long-Term Investments Gene Investing With Anthony on X: https://x.com/GeneInvesting Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorr Text"
YouTube Link 2025-05-27T22:56Z 75K followers, [---] engagements

"Six months to Q3 [----] NDA See the flaw. A crucial regulatory submission looms by Q3 [----] but the path there might be shorter than anticipated. Experts suggest studies can run concurrently drastically altering the six-to-nine month estimate. The surprising revelation Sophisticated financial minds seem to be overlooking this critical parallel processing possibility leaving a major timeline detail unaddressed. #NDAsubmission #BiotechTimeline #RegulatoryAffairs #FinancialAnalysis #PharmaNews BiotechTimeline FinancialAnalysis NDAsubmission PharmaNews RegulatoryAffairs BiotechTimeline"
YouTube Link 2026-02-07T00:56Z 62.3K followers, [---] engagements

"Exit Strategy 2030: Are You Hitting The Target EBITDA 💰 See The Numbers That Matter A fascinating look into the financial benchmarks setting the stage for [----] business exits. The discussion reveals distinct EBITDA targets: a substantial $5 million valuation seems key for a full acquisition scenario. Alternatively for those seeking a Private Equity partnership focusing on scalability the entry point might sit closer to $1 million provided the growth trajectory is compelling. This perspective is crucial for founders currently in the thick of year four of their scaling journey. #BusinessExit"
YouTube Link 2026-02-07T19:30Z 62.3K followers, [---] engagements

"The ONE Small Form That Can Kill a Drug's FDA Approval. Experts reveal the shocking reality: administrative hiccups even a seemingly insignificant oversight like missing HIPAA consent documentation in mapping possess the power to derail an entire multi-million dollar drug approval process. Witness the intense scrutiny applied to study data via [---] observations and understand what critical procedural mistakes can jeopardize years of work and massive investments before the FDA. #drugapproval #clinicaltrials #FDA #compliance #HIPAA #medicalresearch #pharma FDA HIPAA clinicaltrials compliance"
YouTube Link 2026-02-10T21:50Z 75K followers, [---] engagements

"$IOVA Stock: Next Big Biotech Win with [----] Catalysts Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorr Text "guru" to 855-942-5288 to join VIP list My blog: http://www.TheClinicalTrialsGuru.com My CRO"
YouTube Link 2025-09-29T18:14Z 75K followers, [---] engagements

"FDA Audits: It's Not Random Anymore Discover the surprising shift in the Food and Drug Administration's approach to site inspections. Learn how a deep dive into risk analysis dictates which clinical trial locations face scrutiny sometimes focusing on unexpected targets. Unpacking the crucial factors that flag a site for an official look like overwhelming patient enrollment numbers. This perspective changes everything about site compliance strategy. #FDA #ClinicalTrials #SiteAudits #RiskBasedAnalysis #RegulatoryCompliance #ClinicalResearch ClinicalResearch ClinicalTrials FDA"
YouTube Link 2026-02-11T00:04Z 75K followers, [---] engagements

"Doctor vs. FDA: Who Decides Your Treatment A look at the surprising legal battle over ivermectin during the pandemic reveals a critical question: When regulatory bodies try to dictate a doctor's prescription where does patient choice end The courts once affirmed the doctor-patient relationship over FDA mandates but the landscape appears to be changing. This clip examines the fine line between medical guidance and governmental overreach in off-label drug use. #MedicalAutonomy #OffLabelUse #FDA #DrugRegulation #Ivermectin #HealthcareDebate #LegalBattle #PatientRights DrugRegulation FDA"
YouTube Link 2026-02-08T19:13Z 72.5K followers, [---] engagements

"Secret FDA loophole Drug approval without research Certain historical data carries surprising weight with regulators. An intriguing look at how a "paper NDA" can unlock drug approval pathways leveraging centuries-old usage data where traditional studies might fall short. For those tracking regulatory mechanics a peek into the FDA's own Manual of Administrative Procedures reveals operational insights that even keen observers might find illuminating regarding internal guidelines. #DrugApproval #FDA #Pharmaceuticals #MedicalNews #RegulatoryAffairs #HealthcareInnovation DrugApproval FDA"
YouTube Link 2026-02-08T16:49Z 72.5K followers, [--] engagements

"The Million Dollar Gatekeeper: Is Your Business Ready for a PE Acquisition Unlocking the door to a lucrative private equity exit requires hitting a very specific financial benchmark. Observers note that interested PE firms are laser-focused on the trailing twelve months' performance. For a serious conversation to even begin the magic number they're looking for is a minimum of one million dollars in EBITDA from that recent yearly period. It's a non-negotiable starting point that separates the potential targets from the rest of the field. Understanding this TTM metric is crucial for anyone"
YouTube Link 2026-02-06T22:15Z 60.6K followers, [--] engagements

"OTC game-changer The path to front-of-store shelves revealed Experts weigh in on what it will take for this item to hit the over-the-counter market. Solid data and meticulous packaging are non-negotiable hurdles. A top executive noted the FDA's high bar for preventing medication errors even beyond just devices. What's the first domino that needs to fall for this accessibility shift #OTC #Pharmaceuticals #FDA #Approval #HealthInnovation #NextBigThing #DrugSafety Approval DrugSafety FDA HealthInnovation NextBigThing OTC Pharmaceuticals Approval DrugSafety FDA HealthInnovation NextBigThing OTC"
YouTube Link 2026-02-04T01:15Z 82.7K followers, [---] engagements

"FDA CRL DROPS: Clarity or Confusion Ahead A close read of the recent FDA Complete Response Letter reveals surprising direction perhaps foreshadowing the agency's future OTC expanded access strategy. Analysts are zeroing in on the two swift easy-to-enroll studies mandated to address the feedback. This development offers fascinating insight into navigating unpredictable regulatory pathways. #FDA #Biotech #RegulatoryAffairs #ClinicalTrials #PharmaNews #CRL Biotech CRL ClinicalTrials FDA PharmaNews RegulatoryAffairs Biotech CRL ClinicalTrials FDA PharmaNews RegulatoryAffairs"
YouTube Link 2026-02-07T18:22Z 62.3K followers, [---] engagements

"Aquestive Therapeutics $AQST Is Bigger Opportunity Than We Even Thought Aquestive Therapeutics Is Bigger Opportunity Than We Even Thought"
YouTube Link 2026-01-08T00:03Z 72.3K followers, [---] engagements

"PBMs are dying The future of medicine pricing revealed The traditional gatekeepers of prescription drug costs Pharmacy Benefit Managers might be facing obsolescence. Observers suggest a radical pivot toward a Direct-to-Consumer model is replacing how patients get their medicine. Hear the arguments for why the established system which dictates what big corporations' employees pay is finally crumbling. This discussion uncovers the emerging landscape of pharmaceutical access. #Pharmaceuticals #HealthcareReform #PBM #DirectToConsumer #DrugPricing #HealthTech #PharmacyBenefits DirectToConsumer"
YouTube Link 2026-02-13T16:36Z 86.2K followers, [---] engagements

"That iconic 'head in the sand' moment is happening right now in the tech world. Are you watching . The refusal to acknowledge massive shifts is more common than one might think. Network executives and even employees are reportedly choosing willful blindness imagining a reality where today's disruptive tools simply disappear. That approach is pure folly. Reality demands a clear-eyed look at what is unfolding and immediate adoption of the new landscape. The apprehension surrounding these changes is understandable but inaction is the far greater risk. It is time to look up and engage. #AI"
YouTube Link 2026-02-08T00:49Z 75K followers, [---] engagements

"She Was Kicked Out of Zambia for Spying Now She Exposes Medical Fraud Edye Edens Edye's LinkedIn: https://www.linkedin.com/in/edyetedens/ My substack FREE: https://substack.com/@dansfera1r=27gh4e&utm_medium=ios&utm_source=profile Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK"
YouTube Link 2026-02-11T12:15Z 75K followers, [--] engagements

"What Is An IRT System In Clinical Research The University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/ Text Me: (949) 415-6256 My podcast is Random Musings From The Clinical Trials Guru Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/dp/1090349521/. Text "guru" to 855-942-5288 to join VIP list My blog: http://www.TheClinicalTrialsGuru.com My CRO and Site Network: http://www.DSCScro.com My CRA Academy: http://www.TheCRAacademy.com My CRC Academy: http://www.TheCRCacademy.com Latinos In Clinical Research:"
YouTube Link 2022-05-31T19:00Z 75K followers, [----] engagements

"Clinical Research Associate (CRA) Job Responsibilities CRIO: http://www.clinicalresearch.io Inato: https://go.inato.com/3VnSro6 Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 My podcast is Random Musings From The Clinical Trials Guru Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorr Text "guru" to 855-942-5288 to join VIP list My blog: http://www.TheClinicalTrialsGuru.com My"
YouTube Link 2024-05-09T12:15Z 75K followers, 12K engagements

"Forget the old way The FDA is tapping into predictive AI to radically change how drugs get appro. A fascinating look at the cutting edge of pharmaceutical regulation. The discussion reveals how the Food and Drug Administration is exploring a seismic shift in clinical trial architecture. Instead of rigid sequential stages advanced predictive analyticsspecifically Bayesian modelingare being examined to streamline the process. Imagine condensing phases one and two or two and three based on superior predictive pre-screening. This powerful statistical tool allows for a more predictive assessment"
YouTube Link 2026-02-10T01:46Z 75K followers, [---] engagements

"Forget $100 Million: This Risk Is Different. One analyst breaks down why this seemingly huge setback is financially a fraction of the expected disaster. The difference between a major write-off and a manageable contingency especially when contingent funding hangs in the balance changes the entire risk profile. A fascinating look at financial optics. #FinancialRisk #BusinessStrategy #Investment #Contingency #MarketAnalysis BusinessStrategy Contingency FinancialRisk Investment MarketAnalysis BusinessStrategy Contingency FinancialRisk Investment MarketAnalysis"
YouTube Link 2026-02-08T01:44Z 70.1K followers, [---] engagements

"The SCARY truth about letting algorithms run your life. Are you already obsolete A powerful perspective surfaces about the current push toward algorithmic dependency. Many people are unknowingly handing over their critical thinking which experts suggest could lead to being replaced by the very tools they rely on. One individual shares a defiant stance: rather than resisting the tools entirely the strategy becomes mastering the underlying principles to carve out a sustainable independent path even if it's not on the global stage. It's a sharp look at digital self-preservation and reclaiming"
YouTube Link 2026-02-09T16:09Z 75K followers, [---] engagements

"Bootlegging or Brilliant The HIMS Drug Debate The discussion dives deep into the questionable practices surrounding certain pharmaceutical marketing. What happens when a company markets a product variant without labeling it as such Hear the sharp exchange on whether this strategy crosses the line from clever formulation to outright imitation. Patients might be unaware of the subtle yet crucial differences in these treatments. A must-listen for anyone following the evolving landscape of accessible healthcare options. #HIMS #CompoundingPharmacy #DrugMarketing #HealthcareDebate #Pharmaceuticals"
YouTube Link 2026-02-12T19:55Z 82.7K followers, [--] engagements

"Your Doctor Your Rx: Where Does the Line Get Drawn A fascinating exchange surfaces regarding medical autonomy. When a provider recommends a specific protocol involving new medications should the final approval rest solely between that expert and the individual receiving care The discussion takes a sharp turn when comparing this dynamic to restrictions placed on other specialized treatments. Explore the tension point where prescription power compounding pharmacy involvement and patient choice intersect. Its a critical look at who truly controls the path to wellness. #medical #autonomy #patient"
YouTube Link 2026-02-12T01:03Z 82.7K followers, [---] engagements

"One bad site derails the whole drug trial Shocking truth The FDA's Form [---] looms large for research sites but sponsors might not fully grasp the immense risk. See how a seemingly small fraction of compromised data from just one underperforming site can seriously jeopardize an entire multi-million dollar clinical investigation. The ripple effect is far greater than most anticipate. #ClinicalTrials #DrugDevelopment #FDA483 #ResearchSite #PharmaRisk ClinicalTrials DrugDevelopment FDA483 PharmaRisk ResearchSite ClinicalTrials DrugDevelopment FDA483 PharmaRisk ResearchSite"
YouTube Link 2026-02-09T00:07Z 75K followers, [---] engagements

"Ditch the Corporate Ladder Why Smart Creators Are Choosing Small Over HUGE Networks 🤯 Perspective shift Many are finding that cultivating relationships within smaller site networks offers an unexpected sanctuary in today's digital landscape. While the trade-offs like potential financial instability or lack of traditional benefits are real considerations the gains in flexibility and genuine team collaboration paint a compelling picture. Workers finding themselves in these nimble environments are discovering a key advantage: instead of fearing replacement by automation they are being"
YouTube Link 2026-02-09T00:12Z 71K followers, [---] engagements

"AI reveals hidden FDA red flags 🚩 Smart investors set up AI systems to instantly flag new FDA Warning Letters. Why this approach It provides a real-time pulse on regulatory scrutiny offering a crucial edge. For those holding stock sifting through these documents even with potential filler uncovers vital operational concerns missed by general market analysis. A sharp tactic for spotting lurking corporate vulnerabilities before they become headlines. #AI #StockMarket #FDA #InvestingTips #RiskManagement #TechAlerts AI FDA InvestingTips RiskManagement StockMarket TechAlerts AI FDA InvestingTips"
YouTube Link 2026-02-08T20:19Z 70.1K followers, [--] engagements

"$iova deep dive due diligence $iova deep dive due diligence"
YouTube Link 2025-08-25T00:04Z 75K followers, [---] engagements

"StreamYard alternative DROPS the hammer 🤯 This deep dive exposes why creators are migrating from StreamYard to newer platforms boasting superior features like a handy countdown function. The core issue seems tied to its acquisition by Bending Spoons with many observers noting a sharp shift toward unwelcome business practices. It's the classic tale: a beloved tool receives massive investment leading users to feel progressively nickel-and-dimed. Discover the evidence suggesting the reign of the former streaming favorite might be coming to an end. #streaming #software #live #streaming"
YouTube Link 2026-02-10T18:18Z 75K followers, [---] engagements

"Career Pivots For Clinical Research Associates My substack FREE: https://substack.com/@dansfera1r=27gh4e&utm_medium=ios&utm_source=profile Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorr Text "guru""
YouTube Link 2026-02-10T16:51Z 75K followers, [---] engagements

"Gout Drug Approval: Centuries Too Late The pharmaceutical journey of colchicine offers a fascinating look at medical validation. Imagine proving what history already confirmed centuries ago This clip highlights a truly head-scratching moment in the quest for regulatory approval where a treatment historically associated with royalty and the rich finally gets its official modern stamp. A testament to process perhaps but certainly a prime example of the "No Shit Sherlock" phenomenon. #gout #colchicine #medicalhistory #fdaapproval #drugdiscovery #medicalfacts #historyofmedicine colchicine"
YouTube Link 2026-02-09T23:14Z 75K followers, [---] engagements

"HIMS: Buy the Dip or DOJ Danger Zone The fate of HIMS hangs in the balance. Observers are seriously debating whether the recent stock slump presents a compelling entry point or if lingering regulatory shadows make it too risky. Analysts dissect the current billion-dollar market cap and ponder what the next chapter for this health platform truly holds. The conviction level remains mixed making this a critical moment for potential investors to watch. #HIMS #StockMarket #Investing #HealthTech #StockAnalysis #DOJ DOJ HIMS HealthTech Investing StockAnalysis StockMarket DOJ HIMS HealthTech"
YouTube Link 2026-02-11T19:25Z 75K followers, [----] engagements

"SCENARIO SHIFT: The FDA boogeyman is gone. What does this mean for the future of innovation and i. A major shift is underway concerning federal oversight. Observers note that the period of paralyzing regulatory doubt has concluded. Far from stifling progress the current climate appears aligned with accelerating scientific exploration though the pathway itself is being re-engineered. Forget the old mandates; the established multi-phase testing structure is facing serious scrutiny perhaps streamlining processes akin to those used for expedited pathways. The underlying drive appears to be"
YouTube Link 2026-02-08T19:57Z 75K followers, [---] engagements

"Is IOVA the next big thing Find out why this investor couldn't resist adding more shares The latest developments surrounding IOVA are creating quite a buzz in the investment community. With its promising trial results the outlook for laphylocel and non-small cell lung cancer has never looked brighter. An enthusiastic investor shares their perspective on this stock explaining the rationale behind their recent purchase and how everything points toward a strong future for the company. Could this be the opportunity you've been waiting for Discover the insights behind the hype and why this is a"
YouTube Link 2025-11-11T01:22Z 62.3K followers, [---] engagements

"$ATAI Stock: AtaiBeckley FDA Breakthrough Status & The $12 Target: BPL 003's [--] Hour Game Changer Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorr Text "guru" to 855-942-5288 to join VIP list My blog:"
YouTube Link 2025-11-13T02:31Z 75K followers, [---] engagements

"AI is lying to you. See why Serious decisions require more than a string of AI answers. A startling realization emerges: relying on multiple AI models is just having one algorithm second-guess another. Discover the critical flaw in current large language model output that mandates human oversight for any sensitive information. The data simply isn't there yet for blind faith. #AI #ArtificialIntelligence #DataTrust #LLM #TechWarning #FutureofWork AI ArtificialIntelligence DataTrust FutureofWork LLM TechWarning AI ArtificialIntelligence DataTrust FutureofWork LLM TechWarning"
YouTube Link 2026-02-11T01:37Z 75K followers, [---] engagements

"Are YOU asking the RIGHT questions 🤯 This simple approach uncovers HUGE blind spots A fascinating look at the relentless pursuit of improvement One individual discovers that their intense curiosity and barrage of clinical questions aimed at ironing out inefficiencies and identifying gaps places them high on the internal poll of most inquisitive team members. The real takeaway Even someone who thinks they ask all the questions isn't actually number one Discover the mindset that drives constant evolution and why relentless inquiry is a sign of genuine engagement not annoyance. A must-watch"
YouTube Link 2026-02-09T18:48Z 75K followers, [---] engagements

"That infamous [---] audit screenshot Total noise See the real story. The story circulating about the January [----] manufacturing audit findings gets a complete reversal here. What was presented as a major red flagthat dreaded Form [---] screenshotturns out to be pure noise based on incomplete data. Reviewing the supposed evidence even under worst-case assumptions demonstrates why this particular piece of information should be ignored. A fascinating look at how easily miscontextualized data can cause industry panic. #FDAAudit #ManufacturingCompliance #Form483 #AuditDebunked #IndustryAnalysis"
YouTube Link 2026-02-07T19:56Z 62.3K followers, [---] engagements

"$SPRY Neffy Citizens Petition To FDA To Block $AQST Anaphylm Analysis Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorr Text "guru" to 855-942-5288 to join VIP list My blog:"
YouTube Link 2025-10-29T00:30Z 75K followers, [---] engagements

"Congress writes laws. The FDA decides life or death. The scope of Congressional law like the Food Drugs and Cosmetics Act often leaves critical details vague. Observe how the Executive Branch agencies such as the FDA must translate sweeping mandates like "no adulteration" into highly specific nuanced rules for cutting-edge fields like gene therapya translation with potentially life-or-death consequences. It's fascinating to see the gap between initial lawmaking and its complex real-world enforcement. #FDA #Regulation #GeneTherapy #LawInterpretation #FDCA #ExecutiveBranch ExecutiveBranch FDA"
YouTube Link 2026-02-09T01:32Z 72.5K followers, [---] engagements

"The Miami Meltdown With Edye Edens: Could This Scandal Change the CRO/Sponsor Relationship Forever Edye's LinkedIn: https://www.linkedin.com/in/edyetedens/ My substack FREE: https://substack.com/@dansfera1r=27gh4e&utm_medium=ios&utm_source=profile Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK"
YouTube Link 2026-01-22T12:15Z 62.3K followers, 13.2K engagements

"The SECRET behind free EMR tools Hint: It's not kindness. 🤯 This segment exposes the surprising calculus behind seemingly generous health system practices. Offering Electronic Medical Records (EMRs) and essential tools for free isn't about pure charity; it's a strategic play for the ultimate commodity. As AI dominates the scarcity shifts entirely to high-quality real-world data. The old adage "Garbage in garbage out" underscores why access to genuine patient information has become the new gold standard making it the real price of admission for any advanced toolset. #DataIsTheNewGold"
YouTube Link 2026-02-05T21:01Z 62.3K followers, [---] engagements

"Clinical Trials: The Real Price Tag & Investor Payday. Someone deeply embedded in research site operations reveals the staggering financial reality behind getting crucial clinical study data. Discover the typical budget ranging from $750000 to $1.5 million and the tight four-to-six-month window from first to last patient. The real kicker The market's predictable reaction once those numbers are finalizedoften resulting in a rapid 15% to 20% boost for the associated stock. An insider look at how science meets the market. #ClinicalTrials #BiotechInvesting #PharmaFinance #StockMarketInsights"
YouTube Link 2026-02-07T23:56Z 75K followers, [---] engagements

"Bought the 40% surge top High conviction play or instant regret A classic market moment captured: one investor fueled by positive news and excitement dives back in right as a stock rockets up 40%. The purchase was made near the peak doubling down after a previous strategic move to reduce risk in the last cycle. A fascinating look at the psychology of chasing a massive gainwas this bravery or folly The conviction remains even after buying at the high. #stockmarket #investing #trading #FOMO #stockanalysis #momentumtrading FOMO investing momentumtrading stockanalysis stockmarket trading FOMO"
YouTube Link 2026-02-05T23:42Z 56.5K followers, [---] engagements

"Mastering the Chaos of Clinical Trials Navigating the world of clinical trials isn't for the faint of heart. Balancing responsibilities across [--] to [--] studies while collaborating with multiple Clinical Trial Managers (CTMs) and Clinical Research Associates (CRAs) requires not only skill but also finesse. Discover the intricacies of project management in clinical research where efficient resource allocation and team coordination are paramount. Gain insights into the challenges faced by project managers and learn how they ensure success across diverse studies from site management to team"
YouTube Link 2025-01-23T06:57Z 82.7K followers, [----] engagements

"Oversight Gone The Miami Sponsor Nightmare. When an organization completely delegates oversight disaster often follows. The recent Miami sponsor situation serves as a stark warning: relying solely on an external expert like a CRO to manage everything leaves a massive liability gap if they stumble. True control can never be fully offloadedthe consequences of that lapse are severe. This segment dissects where the line between hiring help and losing the reins gets dangerously blurred. #BusinessRisk #Outsourcing #CRO #RiskManagement #BrandSafety #CorporateGovernance BrandSafety BusinessRisk CRO"
YouTube Link 2026-02-12T18:19Z 82.7K followers, [---] engagements

"Clinical Research Study Start Up Regulatory Documents Explained Quickly The University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/ Text Me: (949) 415-6256 My podcast is Random Musings From The Clinical Trials Guru Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/dp/1090349521/. Text "guru" to 855-942-5288 to join VIP list My blog: http://www.TheClinicalTrialsGuru.com My CRO and Site Network: http://www.DSCScro.com My CRA Academy: http://www.TheCRAacademy.com My CRC Academy: http://www.TheCRCacademy.com"
YouTube Link 2022-03-26T00:24Z 70.8K followers, 18.9K engagements

"FDA Rejection The Details Might Surprise You. The market's reaction might be overblown. This analysis reveals why the recent Complete Response Letter is characterized as 'clean'restricted only to mechanical hurdles with management explicitly stating the FDA raised zero red flags regarding critical clinical endpoints like blood pressure or variability. Wait for the official release to confirm the full story behind this hurdle. #FDA #CRL #BiotechNews #DrugApproval #InvestmentInsights #PharmaUpdate BiotechNews CRL DrugApproval FDA InvestmentInsights PharmaUpdate BiotechNews CRL DrugApproval FDA"
YouTube Link 2026-02-06T01:59Z 56.5K followers, [---] engagements

"Speed vs. Safety: How Fast Should Cures Arrive 🤯 The burning question surfaces: Should clinical trial timelines be drastically cut While safety remains paramount a powerful argument emerges for accelerating innovation. Discover the tension between a patient's desire for quicker access to potential breakthroughs and the rigorous standards protecting public health. Where does the line truly get drawn for established safety benchmarks versus rapid efficacy testing A fascinating look at the core dilemma facing modern medicine. #FDA #ClinicalTrials #PatientSafety #DrugApproval #MedicalEthics"
YouTube Link 2026-02-08T17:26Z 75K followers, [---] engagements

"CROs: Record Profits or Race to the Bottom The pursuit of bottom-line growth by publicly traded CROs hints at a worrying downward spiral for clinical research standards. While some industry analysts report record profits regulatory red flags including spikes in inadequate monitoring detailed in FDA reports suggest sponsors may soon tire of the current cost-cutting environment. Observers suggest the writing is on the wall for CRO market share against more agile site networks. A fascinating look at where the industry's financial incentives are currently leading. #ClinicalResearch #CROs"
YouTube Link 2026-01-31T01:12Z 71K followers, [---] engagements

"They Bought 5k Shares Will This Stock Reach $7 The $7 upside for this particular stock seems plausible based on the anticipated trial results. An investor just added [----] shares to their position viewing anything under $5 as an excellent entry point. Important milestones ahead include a Type A meeting and the launch of key studies culminating in an NDA submission in the third quarter. The countdown to major catalysts is officially on #StockMarket #PricePrediction #InvestmentStrategy #MarketCatalyst #FinancialNews FinancialNews InvestmentStrategy MarketCatalyst PricePrediction StockMarket"
YouTube Link 2026-02-06T23:47Z 71K followers, [---] engagements

"AI is coming for the budget: Prepare for the squeeze 📉 A stark look at the near future where the integration of artificial intelligence and aggressively streamlined processes become the new standard. The consensus points toward a 'take it or leave it' approach to corporate budgeting inevitably tightening financial margins across the board for the coming ten years. Essential viewing for anyone planning their strategy for the next decade. #AI #BusinessStrategy #FutureOfWork #Finance #Automation #TechTrends #Economy #MarginSqueeze #YouTubeShorts AI Automation BusinessStrategy Economy Finance"
YouTube Link 2026-02-09T20:41Z 75K followers, [--] engagements

"Epinephrine Film: PDUFA Battle Why ARS Pharma $spry is Trying to Delay Anaphylm Approval $AQST OASIS study presentation: https://investors.aquestive.com/static-files/46303091-5060-4893-bb80-7be00a833927 Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK"
YouTube Link 2025-11-12T00:17Z 75K followers, [---] engagements

"The SECRET to multi-location business growth It's all about the tech you standardize 🚀 Achieving true platform status demands more than just local success; it requires proving the ability to scale geographically with absolute consistency. This piece explores the crucial strategy: codifying the entire technology ecosystemfrom patient management systems like Creo and Patient Ace to workflow tools like Monday and Gleaminto a single replicable blueprint. The logic is simple: any future partner or new site inherits a fully operational proven framework making rapid repeatable expansion the only"
YouTube Link 2026-02-08T21:23Z 75K followers, [--] engagements

"What Makes Oncology Clinical Trials Unique From Others - A Clinical Research Site Perspective Join this channel to get access to perks: https://www.youtube.com/channel/UCvw9kVKHEyAlZPZ6ZuOd2VA/join Text Me: (949) 415-6256 My podcast is Random Musings From The Clinical Trials Guru Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/dp/1090349521/. Text "guru" to 855-942-5288 to join VIP list My blog: http://www.TheClinicalTrialsGuru.com My CRO and Site Network: http://www.DSCScro.com My CRA Academy: http://www.TheCRAacademy.com My CRC"
YouTube Link 2021-11-30T19:52Z 82.7K followers, [----] engagements

"CRA Followed & Threatened in Miami The Wildest Clinical Research Fraud Allegations Exposed Carla's LinkedIn: https://www.linkedin.com/in/carla-vera-navas-9b5a2439/ My substack FREE: https://substack.com/@dansfera1r=27gh4e&utm_medium=ios&utm_source=profile Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK"
YouTube Link 2026-01-15T23:32Z 75K followers, 27.2K engagements

"What Are My Thoughts On Masters In Clinical Research Degrees What Are My Thoughts On Masters In Clinical Research Degrees Text Me: (949) 415-6256 My podcast is Random Musings From The Clinical Trials Guru Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/dp/1090349521/. Text "guru" to 855-942-5288 to join VIP list My blog: http://www.TheClinicalTrialsGuru.com My Private Member Patreon Page: http://www.patreon.com/dansfera My CRO and Site Network: http://www.DSCScro.com My CRA Academy: http://www.TheCRAacademy.com My CRC Academy:"
YouTube Link 2021-06-01T15:03Z 75K followers, [----] engagements

"HIMS at $17: Rocket to $8 or massive crash The DOJ is watching A sharp look at HIMS as it trades near seventeen. Analysts are openly debating whether this stock is primed for an explosive move to eight dollars or beyond. The underlying sentiment suggests fear is at an all-time high fueled by the serious implications of the FDA escalating matters to the Department of Justice. This development signals a long road ahead contrasting sharply with recollections of buying at the previous six-figure peak valuation. The charts tell a compelling albeit nervous story. #HIMS #StockMarket #FDA #DOJ"
YouTube Link 2026-02-11T16:36Z 75K followers, [---] engagements

"$Iova with the earnings turnaround Stock pumps $Iova with the earnings turnaround Stock pumps"
YouTube Link 2025-11-06T23:12Z 75K followers, [---] engagements

"FDA Cracks Down On $HIMS and Others FDA Cracks Down On $HIMS and Others"
YouTube Link 2026-02-10T20:20Z 75K followers, [---] engagements

"FDA's bizarre guidance move explained A fascinating procedural anomaly has surfaced: The Food and Drug Administration issued crucial labeling instructions within the Complete Response Letter itself a step usually reserved for the earlier review phase. Observers noted this break from convention during the call. Could this highly unusual action signal that regulators are meticulously setting the stagegathering necessary data and precedentfor a future over-the-counter pilot product launch An interesting perspective on agency strategy. #FDA #RegulatoryAffairs #DrugApproval #LabelingGuidance #OTC"
YouTube Link 2026-02-04T23:51Z 75K followers, [---] engagements

"De-risked and Boring $AQST and Excitement Filled $IOVA - Biotech Stock Talk AQST and IOVA Biotech Stock Talk"
YouTube Link 2026-02-03T23:01Z 75K followers, [---] engagements

"The shocking reason hospitals are running out of essential meds. The economics of pharmaceuticals reveal a startling vulnerability in healthcare. When generic drug margins shrink to 'paper thin' manufacturers simply walk away causing a cascade effect. Imagine a hospital facing empty shelves where life-saving chemotherapy should be. The reality involves technicians frantically compounding essential medications just to keep patients alive. Discover the systemic failure behind the alarming rise in critical drug shortages. #drugshortages #pharmaceuticals #healthcarecrisis #genericdrugs"
YouTube Link 2026-02-13T01:44Z 86.2K followers, [----] engagements

"$AQST Aquestive Therapeutics' Clean CRL - You Have [--] Months To Load Up My substack FREE: https://substack.com/@dansfera1r=27gh4e&utm_medium=ios&utm_source=profile Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK"
YouTube Link 2026-02-02T23:28Z 75K followers, [---] engagements

"FDA Inspectors: Who's really at fault Site vs. Protocol breakdown Unpacking the tough reality behind failed FDA site inspections. When two sites stumble on the same process is the issue the people or is the foundational study guide itself flawed Discover the critical shift in perspective when determining accountability for reporting failures. This analysis separates the site's execution from the protocol's design. #FDAReview #ClinicalTrials #SiteAudit #ProtocolDesign #RegulatoryCompliance #PharmaInsights ClinicalTrials FDAReview PharmaInsights ProtocolDesign RegulatoryCompliance SiteAudit"
YouTube Link 2026-02-12T16:03Z 82.7K followers, [---] engagements

"Forget the NBA DraftThis Team Just Landed Their Own Victor Wembanyama 🤯 The buzz is real over the incredible new addition to the team: Dora an international medical graduate staff member. The consensus is clearthis hiring move rivals the biggest steals in sports history. Listen as the hosts break down why landing this exceptional talent feels like winning the lottery comparing the potential to securing a generational athlete like Victor Wembanyama for the Spurs. The standard for top-tier talent has just been redefined #MedicalStaff #InternationalMedicalGraduate #HealthcareTalent #Wemby"
YouTube Link 2026-02-08T19:01Z 71K followers, [---] engagements

"FDA "Rejection" = Next Year's HUGE Buying Window Many anticipated a clear path forward but the market received a less than ideal outcome. This surprising turn of events has unexpectedly gifted the disciplined investor a full extra year. That twelve-month runway provides significant time to strategically load up on assets during any temporary downturns provided one can successfully ignore the surrounding market chatter. The true value here lies in the extended window granted to those playing the long game. #FDA #BiotechInvesting #StockMarket #BuyingTheDip #InvestmentStrategy"
YouTube Link 2026-02-03T21:03Z 56.5K followers, [---] engagements

"Clinical research associates essentially get their hours arbitraged by the CROs"
YouTube Link 2026-02-12T16:35Z 82.7K followers, [---] engagements

"Massive Medical Research Fraud CASE Just Blew Up In Miami 🤯 A shocking expos reveals systemic deception in a recent Miami clinical study. Five key sites contributing half the data pool were found to be operating on fabricated patient records and template-copied MRI results across the board. The situation escalated dangerously when an independent auditor faced threats of physical harm during an investigation. The root of this massive deception appears to be a deep-seated conflict of interest linking a CRO executive directly to leadership roles at the compromised research sites. The fallout"
YouTube Link 2026-02-06T18:09Z 56.5K followers, [--] engagements

"FDA agents mingling with reps The undercover truth revealed Imagine the scene: FDA officials walking convention floors engaging sales teams post-launch. A sales representative's moment of truthare they aware of the regulatory tightrope they're walking Discover the fascinating dynamic when the industry meets its watchful eye all while giving a special nod to the reps who inadvertently supply the case studies. #FDA #MedicalSales #RegulatoryAffairs #ConventionLife #PharmaSales ConventionLife FDA MedicalSales PharmaSales RegulatoryAffairs ConventionLife FDA MedicalSales PharmaSales"
YouTube Link 2026-02-11T20:00Z 75K followers, [---] engagements

"Investor Alert: FDA Audits Hold Market Secrets Savvy investors know the real story isn't just the science; it's who the SEC is watching. Unpacking the critical questions about FDA audit targets and the penalties for failing to report key trial outcomes. A crucial look at regulatory risk that shapes stock performance. #FDA #SEC #StockMarket #InvestingTips #DueDiligence #HealthcareStocks #AuditRisk AuditRisk DueDiligence FDA HealthcareStocks InvestingTips SEC StockMarket AuditRisk DueDiligence FDA HealthcareStocks InvestingTips SEC StockMarket"
YouTube Link 2026-02-10T19:25Z 75K followers, [---] engagements

"World-Changing Tech: Why They're Holding Back the Future The consensus is emerging: cutting-edge artificial intelligence and staggering leaps in biotechnology are no longer just scientific pursuits; they are fundamental concerns for national security across the globe. Whispers suggest that releasing the full extent of these capabilities immediately would trigger worldwide disruption leading to an unprecedented era of chaos. Someone noted that humanity might already possess the keys to massive transformation but for stability's sake progress is being carefully metered out. What does this"
YouTube Link 2026-02-08T18:10Z 75K followers, [---] engagements

"$AQST Aquestive Therapeutics CRL Dissection With FDA Attorney- FDA Gave Us [--] Free Months AQST and IOVA Biotech Stock Talk"
YouTube Link 2026-02-05T01:43Z 62.3K followers, [---] engagements

"The Rise of AQST: From $300M to New Heights Reflecting on the impressive journey of AQST this discussion highlights its remarkable growth trajectory and potential for further gains. With market sentiments shifting and analysts predicting even more upside the conversation dives deep into whether AQST can soar to new highs. Discover the insights and share the excitement surrounding this dynamic stock as it continues to make waves in the market. #AQST #StockMarket #Investment #MarketTrends #GrowthStocks AQST GrowthStocks Investment MarketTrends StockMarket AQST GrowthStocks Investment"
YouTube Link 2025-11-15T23:09Z 71K followers, [---] engagements

"Ever wondered what the CRA lifestyle is really like 🌍✈ Explore the dynamic world of Clinical Research Associates and the unique challenges they face on the road. This engaging video delves into the reality of constant travel unexpected delays and the strategies CRAs use to balance work and life. With insights into payment structures and a glimpse into mentorship opportunities this is a must-watch for anyone curious about the intricacies of the CRA role. Buckle up for an eye-opening journey that reveals just how demandingand rewardingit can be to be a CRA #CRA #ClinicalResearch"
YouTube Link 2025-03-20T16:15Z 75K followers, [---] engagements

"The $10B question: Are these labs actually following the rules A massive industry is thriving but its foundation rests on a single technicality: Are these 'lab-developed tests' truly just that or something far more regulated Observers are asking if this multibillion-dollar operation masquerades as something minor. The lines blur between a standard lab service a wellness offering and an actual medical device subject to intense scrutiny and inspection. The stakes are high when the difference could mean FDA oversight. A fascinating deep dive into where the regulations actually apply. #regulation"
YouTube Link 2026-02-09T20:45Z 72.5K followers, [--] engagements

"What Does A Clinical Trial Assistant (CTA) Typically Do At A Contract Research Organization (CRO) The University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/ Text Me: (949) 415-6256 My podcast is Random Musings From The Clinical Trials Guru Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/dp/1090349521/. Text "guru" to 855-942-5288 to join VIP list My blog: http://www.TheClinicalTrialsGuru.com My CRO and Site Network: http://www.DSCScro.com My CRA Academy: http://www.TheCRAacademy.com My CRC Academy:"
YouTube Link 2022-03-18T16:33Z 60.8K followers, 11.7K engagements

"The Unstoppable Rise: Is Your Career Field AI-Proof This compelling segment explores the accelerating integration of artificial intelligence across various industries from autonomous vehicles to automated restaurant service. The discussion pivots to the significant looming impact on professional sectors like clinical research. Witness the unsettling reality as technology reshapes the employment landscapea crucial perspective from a leading mind in the tech sphere on where the next wave of automation will land. #AI #Automation #FutureOfWork #TechTrends #ClinicalResearch #JobDisruption"
YouTube Link 2026-02-09T21:24Z 75K followers, [--] engagements

"Site Networks are the NEW CRO An insider's shocking confession on AI and the 'soul' of research 🤯 A startling industry revelation surfaces after a post went viral: an employee from a major site network confirmed a brutal internal reality. The sentiment suggests that the aggressive adoption of Artificial Intelligence is leading to massive layoffs and more alarmingly the systematic eradication of the human elementthe very 'soul' of clinical research operations. This situation forces a profound consideration for every stakeholder: At what point does efficiency become cultural destruction and"
YouTube Link 2026-02-07T18:00Z 62.3K followers, [---] engagements

"Clinical Research Site Level Roles You Can Do Completely Remotely (While They Still Last) My substack FREE: https://substack.com/@dansfera1r=27gh4e&utm_medium=ios&utm_source=profile Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK"
YouTube Link 2026-02-12T23:56Z 86.2K followers, [----] engagements

"Six Months to FDA Decision for Anaphylaxis Treatment A crucial update surfaces regarding a new NDA resubmission expected around September. Observers are noting the standard six-month review period leading up to next February. Interestingly there's precedent suggesting a faster turnaround as one organization secured approval in just four months. This accelerated path is significant given the growing concerns surrounding anaphylactic reactions and the potential for an Expanded Access pathway to address these urgent public health needs. #FDA #Approval #Drug #Development #Anaphylaxis #Medical"
YouTube Link 2026-02-06T22:42Z 75K followers, [--] engagements

"Ozempic: Approved Drug or Wild Claims The Fine Line. An outside observer examines the fine print surrounding Ozempic's uses. When a drug is known for diabetes and weight loss what happens when claims drift into territory like cancer treatment or addiction areas still under intense study The distinction between established evidence and preliminary research is what dictates whether a prescription medication's promotion crosses into legally risky unproven territory. This segment cuts through the noise to reveal the crucial difference. #Ozempic #FDA #DrugRegulation #Pharmaceuticals"
YouTube Link 2026-02-10T01:00Z 75K followers, [---] engagements

"When the CRO Executive is also the Site Advisor. You won't believe the web of connections being. A startling look into the interconnected web where top Contract Research Organization leadership simultaneously holds advisory roles for research sites. This consolidation particularly with Institutional Review Boards owning significant tech stacks and even research facilities raises serious questions about governance and ethical independence. Observing how these deep-seated relationships separateor if they can be separated at allis crucial for understanding the current landscape of clinical"
YouTube Link 2026-02-07T23:18Z 62.3K followers, [--] engagements

"State AGs vs. Doctors: It's about the dosage Legal eagles are focusing their sights not just on prescribing medications for unapproved uses but on a more subtle maneuver: altering the established dosage. Observers note that changing the dose from what the FDA approved is becoming a significant point of vulnerability for physicians potentially inviting scrutiny from state regulators and malpractice suits. This perspective unpacks where the real regulatory 'safe harbor' might have vanished. #DrugSafety #MedicalLaw #OffLabel #DoctorLiability #HealthcareRegulation #StateAG DoctorLiability"
YouTube Link 2026-02-10T23:07Z 75K followers, [---] engagements

"Why Working at a CRO Might Not Be What You Think 🤔 Exploring the hidden truths of clinical research this insightful short dives into the stabilityor lack thereofof working at a large CRO. Discover why contract research organizations are often the first to make difficult decisions like outsourcing and layoffs. While they can serve as a launching pad for your career they come with a level of instability that might surprise many. Learn more about the landscape of clinical research and where the real security lies among sponsors sites and tech vendors. This is an essential watch for anyone in"
YouTube Link 2024-11-12T18:52Z 75K followers, [---] engagements

"90% Approval Rate The FDA's Secret Focus on User Error. A fascinating look at what truly secures regulatory clearance. The focus shifts dramatically when medication error prevention or DEMIPA becomes the chief concern. It turns out the FDA places significant weight not on achieving flawless performance studies but on ensuring packaging won't cause dangerous mistakes even if a user is struggling in a near-panic state. This priority explains why resubmission approval rates climb to an astonishing [--] to [--] percent in these specific cases mirroring the direct parallels observed with NEFI."
YouTube Link 2026-02-05T17:43Z 56.5K followers, [--] engagements

"MAJOR Rule Change Off-Label Prescriptions Under Fire An incredible legal development is shaking up medical practice right now. Certain health information regarding transgender youth is now a point of intense focus for the administration leading to scrutiny over how doctors have historically prescribed treatments "off-label." Even seasoned legal experts may not grasp the full scope of this cutting-edge shift in regulatory oversight. This situation demands attention from anyone involved in healthcare policy and patient advocacy. #legalshift #medicalpolicy #doctorupdate #transhealth"
YouTube Link 2026-02-09T17:44Z 75K followers, [---] engagements

"Are Clinical Trial Sites Facing Extinction Digital Twins Could Change EVERYTHING for Pharma 🤯 The notion that major pharmaceutical players even revered ones like Eli Lilly could soon receive regulatory clearance to sidestep traditional Contract Research Organizations (CROs) and physical testing locations for certain studies is a seismic thought. This perspective delves into a scenario where empowering drug sponsors with sophisticated digital twin simulation technology renders the need for on-site patient recruitment obsolete. Consider the implications when the familiar process of negotiating"
YouTube Link 2026-02-08T22:43Z 75K followers, [--] engagements

"The $7 Stock Trading at CASH Value (26 Days Left) - $VNDA - Vanda Pharmaceuticals - My Swing Trade My substack FREE: https://substack.com/@dansfera1r=27gh4e&utm_medium=ios&utm_source=profile Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK"
YouTube Link 2026-01-26T19:20Z 82.7K followers, [--] engagements

"$800 Million Bets 🤯 What's driving the massive private equity rush to acquire clinical research. The M&A super cycle in clinical research shows no signs of stopping. Witness the staggering figureslike an $800 million deal for a 30-site networkthat lured Private Equity into this specialized sector. Even with a slight pause industry titans like Velocity continue to expand their footprint across hundreds of research locations. This clip unpacks the underlying forces fueling this aggressive consolidation among CROs and investors. A major shift is underway in how clinical trials are being"
YouTube Link 2026-02-09T23:09Z 72.5K followers, [--] engagements

"FDA's REAL priority: Lives over your portfolio gains. The real motivation behind prolonged drug approval processes is laid bare. When regulators choose caution to ensure maximum patient benefit the concerns of market traders and portfolio performance fade into the background. Listen as this analysis cuts through the noise explaining why the FDA's mandate fundamentally separates it from Wall Street's expectations even while acknowledging the high probability of certain study outcomes. #FDA #DrugApproval #Biotech #StockMarket #PatientSafety #PharmaNews #Investing #ClinicalTrials Biotech"
YouTube Link 2026-02-07T16:47Z 62.3K followers, [--] engagements

"The Psychedelic Merger: Inside AtaiBeckley's Rise ($ATAI Stock) Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorr Text "guru" to 855-942-5288 to join VIP list My blog:"
YouTube Link 2025-11-20T05:42Z 75K followers, [---] engagements

"Discipline beats the dips. See the truth behind biotech risk The essential mindset for navigating small-cap biotech investment reveals itself. Smart money understands that true discipline means looking past the constant chatter about dilution risk. Focusing strictly on tangible results is the secret saucea crucial perspective for anyone watching this sector. #investment #discipline #biotech #stocks #market #noise #small #cap #investing #investor #psychology #stock #market #tips biotech cap discipline investing investment investor market noise psychology small stock stocks tips biotech cap"
YouTube Link 2026-02-05T22:36Z 62.3K followers, [--] engagements

"Is the needle officially DEAD 🤯 See the wild future of blood collection Experts are debating whether the current often uncomfortable method of blood collection has an expiration date. Imagine a future where a machine utilizes advanced technologya 'laser eye'to precisely locate a vein and collect a sample before you even leave the waiting area. This clip explores the stunning timeline for when such science fiction could become the medical standard suggesting the change might be closer than we think perhaps even within the next decade. #futuristicmedicine #medicaltechnology #blooddraw"
YouTube Link 2026-02-09T01:35Z 75K followers, [---] engagements

"Nine Months of Market Calm DCA Strategy Revealed Experts are mapping out the next nine months as a period of predictable range-bound trading. Learn the measured approach suggested for navigating these stable waters involving strategic dollar-cost averaging to potentially capitalize on movements between the mid-two and seven price points. A fascinating look at holding steady through the expected sideways action. #MarketAnalysis #DollarCostAveraging #RangeTrading #InvestmentStrategy #TradingTips DollarCostAveraging InvestmentStrategy MarketAnalysis RangeTrading TradingTips DollarCostAveraging"
YouTube Link 2026-02-06T18:40Z 71K followers, [---] engagements

"75 studies for ONE drug The truth about pharma trials is wild Someone just dropped a bombshell about pharmaceutical testing timelines. Is it one study or a mountain of evidence Unpacking the difference between the single pivotal trial and the sheer volume of research actually needed to get a life-saving treatment to market is a serious eye-opener. The numbers might shock you. #DrugApproval #PharmaResearch #ClinicalTrials #ScienceFacts #HealthcareTruth #DrugDevelopment #MedicalScience ClinicalTrials DrugApproval DrugDevelopment HealthcareTruth MedicalScience PharmaResearch ScienceFacts"
YouTube Link 2026-02-08T22:32Z 70.1K followers, [--] engagements

"FDA's Crackdown: Advertising Violations Hit Record Highs The regulatory landscape is heating up Reports indicate a significant surge in advertising violations and CMC deficiencies reaching unprecedented levels. A deep dive reveals that insufficient site monitoring particularly concerning BIMO is emerging as the primary concern leading to numerous [---] observations and stern warning letters for research facilities. This critical trend is slated for serious discussion at the upcoming SOS event. #FDA #AdvertisingCompliance #RegulatoryAffairs #ClinicalTrials #Monitoring #BIMO #WarningLetter"
YouTube Link 2026-02-10T17:08Z 75K followers, [---] engagements

"State lines mean nothing to medical data requests 🤯 Revelations about states demanding patient data from cross-state medical tourism particularly concerning sensitive procedures. The question of jurisdiction over personal health records when crossing state borders is being fiercely tested. A look into the implications for medical privacy across the United States. #MedicalPrivacy #StateLaw #Healthcare #DataSecurity #AbortionAccess #Jurisdiction #USPolitics AbortionAccess DataSecurity Healthcare Jurisdiction MedicalPrivacy StateLaw USPolitics AbortionAccess DataSecurity Healthcare Jurisdiction"
YouTube Link 2026-02-09T23:56Z 75K followers, [--] engagements

"FDA [---] = Drug Death Sentence The surprising truth revealed. Experts debate the true weight of an FDA Form [---] when paired with pivotal trial data. While regulations suggest a handful of key studies suffice the reality for drug approval involves an astonishing average of around [--] trials. Unpacking the nuance between regulatory minimums and the practical hurdles in getting a new medicine to market. This clip offers a fascinating glimpse behind the curtain of pharmaceutical approvals. #pharma #FDA #drugapproval #clinicaltrials #medicalresearch #drugdevelopment #483form #biotech 483form FDA"
YouTube Link 2026-02-09T16:37Z 72.5K followers, [---] engagements

"$AQST FDA NOTIFICATION - Aquestive Therapeutics - MASSIVE BUY OPPORTUNITY IF IM RIGHT My substack FREE: https://substack.com/@dansfera1r=27gh4e&utm_medium=ios&utm_source=profile Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK"
YouTube Link 2026-01-10T18:45Z 62.3K followers, [---] engagements

"How to Sell Your Clinical Research Site Without Killing the Deal Hannah's LinkedIn: https://www.linkedin.com/in/hannahkempski/ My substack FREE: https://substack.com/@dansfera1r=27gh4e&utm_medium=ios&utm_source=profile Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK"
YouTube Link 2026-02-09T18:50Z 75K followers, [---] engagements

"🔬 Latest Biotech Trial Results: Unprecedented Efficacy in Refractory NSCLC $IOVA stock Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorr Text "guru" to 855-942-5288 to join VIP list My blog:"
YouTube Link 2025-11-04T00:02Z 62.3K followers, [---] engagements

"Biotech's Ticking Clock: Is Your Company Ready for the [----] Extinction Line A stark warning echoes through the life sciences sector regarding the next few years. A critical window is suggested to be closing rapidly with [----] looming as the major inflection point. The viewpoint shared is clear: organizations that have not achieved significant differentiation or figured out how to scale effectively face a grim forecast. This could mean being driven out of business being acquired for very little return or simply fading into market irrelevance. This perspective demands immediate strategic focus"
YouTube Link 2026-02-08T00:42Z 75K followers, [---] engagements

"AI vs. 200+ FDA Warning Letters: Game Changer Witness the power shift as leading large language modelsClaude Grok and Geminiare put to the ultimate compliance test. Analyzing hundreds of FDA warning letters once a grueling manual task is now being streamlined by artificial intelligence. See the surprising implications when massive volumes of regulatory documents are processed simultaneously. A major shift for compliance professionals #FDA #WarningLetters #AIAnalysis #RegulatoryCompliance #LLM #PharmaTech #Grok #Gemini #ClaudeAI #Compliance AIAnalysis ClaudeAI Compliance FDA Gemini Grok LLM"
YouTube Link 2026-02-09T22:00Z 72.5K followers, [--] engagements

"HIMS: Bounce Back or Dead Cat Dive Observers are closely watching the recent dip in HIMS. Many believe the sharp decline is overdone anticipating a significant rally very soonperhaps even doubling from current levels. The key question remains: is this dip a temporary correction or the start of a prolonged freefall With serious DOJ and legal clouds hanging over the company the market sentiment is saturated with fear making any quick resolution unlikely. Where does the real value lie now #stockmarket #investment #HIMS #trading #technicalanalysis #marketfear #valuation HIMS investment marketfear"
YouTube Link 2026-02-11T20:19Z 75K followers, [---] engagements

"The FDA's real power exposed See the [--] limits. Someone uncovered the startlingly short list of responsibilities the Food and Drug Administration actually holds regarding pharmaceuticals. It boils down to just four pillars: safety efficacy and avoiding adulteration or misbranding. Anything outside those specific boundaries seems to fall outside their watch. A crucial perspective for anyone concerned about drug oversight. #FDA #DrugSafety #Pharmaceuticals #Regulation #GovernmentOversight #HealthPolicy DrugSafety FDA GovernmentOversight HealthPolicy Pharmaceuticals Regulation DrugSafety FDA"
YouTube Link 2026-02-10T20:20Z 75K followers, [---] engagements

"What You Need to Know About The ACRP Association for Clinical Research Professionals Certifications My substack FREE: https://substack.com/@dansfera1r=27gh4e&utm_medium=ios&utm_source=profile Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK"
YouTube Link 2026-02-06T18:57Z 56.5K followers, [---] engagements

"STOP GUESSING: The Biotech Buyout Formula to Find a $2.50 Stock Worth $22 ($IOVA Case Study) Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorr Text "guru" to 855-942-5288 to join VIP list My blog:"
YouTube Link 2025-11-17T18:33Z 75K followers, [---] engagements

"FDA Secret Risk Analysis: What They Don't Tell You. The stakes are astronomical when a drug designed for a major or rare condition enters a pivotal study. Imagine the tension: a trial where every participant shows an adverse event or conversely where none do. Observers examine the tightrope walk knowing that one of only three sites might determine the fate of this medication. The crucial question remains: how does the governing body weigh these life-altering variables The agency's precise list of considered risks and how they are actually measured remains completely undisclosed. A truly"
YouTube Link 2026-02-09T19:24Z 75K followers, [---] engagements

"Is your research job on the chopping block AI is coming A stark look at which clinical research roles face imminent disruption from automation. Discover the surprising tasks now deemed obsolete and the critical human-centric skills that offer sanctuary from the screen-based takeover. See where the true career longevity lies for CRAs and site staff amidst the rise of intelligent systems. #AIinClinicalResearch #CRACareer #FutureOfWork #ClinicalTrials #JobSecurity #ResearchAutomation AIinClinicalResearch CRACareer ClinicalTrials FutureOfWork JobSecurity ResearchAutomation AIinClinicalResearch"
YouTube Link 2026-02-12T18:51Z 82.7K followers, [--] engagements

"Biotech's nightmare Fed Chairman's actions explained. The market shockwaves are clear: a less aggressive Federal Reserve stance is putting serious pressure on the biotech landscape. Discover why assets like silver and Bitcoin have tumbled and how this high-interest environment suffocates an industry built on future potential. An expert predicts a challenging range-bound year for the entire sector. #Biotech #FederalReserve #InterestRates #StockMarket #Investing #BiotechStocks #MarketAnalysis Biotech BiotechStocks FederalReserve InterestRates Investing MarketAnalysis StockMarket Biotech"
YouTube Link 2026-02-07T19:20Z 62.3K followers, [---] engagements

"30 Years From Now: Is This Career DEAD 🤯 The Future of Research Sites Debated A fascinating glimpse into the future of scientific inquiry. The question hangs in the air: when observers look [--] years ahead to [----] do the current structures of research sites still hold up Hear the candid slightly apprehensive debate on career longevity and the evolution of scientific discovery. It's a deep dive into what might be possible and what might become obsolete for those dedicated to the lab. #researchfuture #sciencecareer #innovation #futureofwork #lablife #technology #speculation #2056 2056"
YouTube Link 2026-02-10T00:04Z 75K followers, [----] engagements

"FDA Regulatory Pathways for Medical Devices - Differences Between 510k PMA and De Novo My substack FREE: https://substack.com/@dansfera1r=27gh4e&utm_medium=ios&utm_source=profile Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK"
YouTube Link 2026-01-30T20:00Z 75K followers, [---] engagements

"$IOVA Due Diligence and EMA Rejection Deep Dive Iovance Biotherapeutics Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorr Text "guru" to 855-942-5288 to join VIP list My blog:"
YouTube Link 2025-10-30T05:57Z 75K followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

@dansfera
/creator/youtube::dansfera